https://curecurrent.com/trials/study-of-the-prevention-of-anal-cancer-130009https://curecurrent.com/trials/women-s-initiative-supporting-health-increasing-healthcare-access-130010https://curecurrent.com/trials/prep-demonstration-project-prelude-study-130011https://curecurrent.com/trials/anakinra-a-recombinant-human-il-1-receptor-antagonist-for-neuroinflammation-in-hiv-1-infection-130012https://curecurrent.com/trials/music-for-health-project-130013https://curecurrent.com/trials/usability-study-of-iehs-in-indonesia-130014https://curecurrent.com/trials/capacity-builders-inc-navajo-youth-builders-personal-responsibility-education-innovation-strategies-project-130015https://curecurrent.com/trials/implementation-effectiveness-and-safety-of-tenofovir-gel-provision-through-family-planning-services-130016https://curecurrent.com/trials/acute-partner-and-social-contact-referral-iknow-130017https://curecurrent.com/trials/cultural-adaptation-and-piloting-of-a-smoking-cessation-intervention-for-smokers-with-hiv-130018https://curecurrent.com/trials/study-to-evaluate-a-hiv-drug-for-the-treatment-of-hiv-infection-130019https://curecurrent.com/trials/observational-data-analysis-in-eurosida-mk-0518-058-130020https://curecurrent.com/trials/quantifying-drug-adherence-and-drug-exposure-to-antiretroviral-therapy-130021https://curecurrent.com/trials/effectiveness-of-a-personalized-health-profile-on-specificity-of-self-management-goals-130022https://curecurrent.com/trials/enlighten-establishing-novel-antiretroviral-arv-imaging-for-hair-to-elucidate-non-adherence-130023https://curecurrent.com/trials/improving-health-outcomes-for-women-living-with-hiv-130024https://curecurrent.com/trials/efficacy-and-safety-of-glecaprevir-pibrentasvir-abt-493-abt-530-in-treatment-naive-and-treatment-experienced-asian-adult-130025https://curecurrent.com/trials/adoptive-transfer-of-haploidentical-natural-killer-cells-and-il-2-130026https://curecurrent.com/trials/understanding-longitudinal-clinical-outcomes-and-post-release-retention-in-care-among-hiv-infected-prisoners-in-lusaka-z-130027https://curecurrent.com/trials/the-safety-pharmacokinetic-profile-and-efficacy-of-raltegravir-in-hiv-infected-patients-at-least-60-years-of-age-130028https://curecurrent.com/trials/impact-of-everolimus-on-hiv-persistence-post-kidney-or-liver-transplant-130029https://curecurrent.com/trials/hiv-prevention-during-chemsex-130030https://curecurrent.com/trials/genetics-and-hiv-1-protease-inhibitors-130031https://curecurrent.com/trials/seek-test-treat-retain-an-integrated-jail-prison-community-model-for-illinois-130032https://curecurrent.com/trials/the-effectiveness-of-sms-in-improving-antiretroviral-medication-adherence-among-adolescents-living-with-hiv-in-nigeria-130033https://curecurrent.com/trials/gene-therapy-treated-stem-cells-in-treating-patients-undergoing-stem-cell-transplant-for-intermediate-grade-or-high-grad-130034https://curecurrent.com/trials/drug-interactions-between-echinacea-purpurea-and-etravirine-130035https://curecurrent.com/trials/pilot-study-of-pyridostigmine-upon-immune-activation-in-hiv-1-patients-who-have-an-inadequate-immune-response-130036https://curecurrent.com/trials/drug-interactions-between-silimarine-and-darunavir-ritonavir-130037https://curecurrent.com/trials/genotypic-tropism-testing-in-proviral-dna-to-guide-ccr5-antagonist-treatment-in-subjects-with-undetectable-hiv-1-viremia-130038https://curecurrent.com/trials/counseling-on-injectable-contraception-and-hiv-risk-in-tanzania-130039https://curecurrent.com/trials/cryotherapy-vs-leep-to-treat-cervical-intraepithelial-neoplasia-cin-2-3-among-hiv-positive-women-130040https://curecurrent.com/trials/the-safety-and-immunogenicity-of-a-potential-hiv-vaccine-130041https://curecurrent.com/trials/social-media-based-peer-led-intervention-for-hiv-prevention-130042https://curecurrent.com/trials/new-strategies-to-assess-anal-cancer-risk-in-women-130043https://curecurrent.com/trials/study-of-simtuzumab-in-hiv-and-or-hepatitis-c-infected-adults-with-liver-fibrosis-130044https://curecurrent.com/trials/tobacco-assessment-and-intervention-with-low-income-persons-living-with-hiv-aids-plwha-in-community-based-aids-service-o-130045https://curecurrent.com/trials/economic-and-social-empowerment-to-increase-upwards-mobility-among-women-130046https://curecurrent.com/trials/the-maraviroc-central-nervous-system-cns-study-130047https://curecurrent.com/trials/increasing-motivation-for-antiretroviral-therapy-initiation-a-pilot-intervention-130048https://curecurrent.com/trials/understanding-the-increased-risk-of-cardiovascular-disease-in-people-with-hiv-130049https://curecurrent.com/trials/the-maraviroc-darunavir-ritonavir-once-daily-pharmacokinetic-study-130050https://curecurrent.com/trials/raltegravir-cerebrospinal-fluid-pharmacodynamic-study-in-hiv-infected-individuals-130051https://curecurrent.com/trials/elvitegravir-evg-cerebrospinal-fluid-csf-pharmacokinetics-in-hiv-infected-individuals-130052https://curecurrent.com/trials/single-dose-study-of-mk-4250-monotherapy-in-anti-retroviral-therapy-naive-human-immunodeficiency-virus-hiv-1-infected-pa-130053https://curecurrent.com/trials/kinetics-of-hiv-rna-decay-in-seminal-plasma-of-men-treated-by-dolutegravir-at-the-time-of-primary-hiv-infection-130054https://curecurrent.com/trials/evaluation-of-the-effect-of-3hp-vs-periodic-3hp-vs-6h-in-hiv-positive-individuals-130055https://curecurrent.com/trials/project-impact-improving-memory-performance-by-applying-cognitive-training-130056https://curecurrent.com/trials/amb-dose-for-cryptococcal-meningitis-130057https://curecurrent.com/trials/resilience-intervention-for-older-hiv-infected-women-130058https://curecurrent.com/trials/switch-study-to-evaluate-f-taf-in-hiv-1-infected-adults-who-are-virologically-suppressed-on-regimens-containing-abc-3tc-130059https://curecurrent.com/trials/smart-linkage-to-hiv-care-via-a-smartphone-app-130060https://curecurrent.com/trials/fostering-resilience-to-psychosocial-and-hiv-risk-in-indian-msm-130061https://curecurrent.com/trials/evaluate-the-tolerability-and-therapeutic-effects-of-repeated-doses-of-autologous-t-cells-with-vrx496-in-hiv-130062https://curecurrent.com/trials/a-functional-performance-study-of-the-wondaleaf-female-condom-130063https://curecurrent.com/trials/hiv-diagnosis-and-treatment-at-birth-for-newborn-with-high-risk-hiv-exposure-130064https://curecurrent.com/trials/hiv-and-hcv-infections-in-2-communes-from-the-battambang-province-cambodia-prevalence-rates-viral-strains-and-unsafe-inj-130065https://curecurrent.com/trials/to-assess-neuroinflammation-and-neurocognitive-function-in-patients-with-acute-hepatitis-c-and-chronic-hiv-co-infection-130066https://curecurrent.com/trials/project-nexus-providing-online-counseling-for-home-based-hiv-testing-130067https://curecurrent.com/trials/implementation-of-nucleic-acid-amplification-testing-screening-to-identify-acute-and-early-hiv-infection-130068https://curecurrent.com/trials/changes-in-cerebral-function-in-treatment-naive-hiv-1-infected-subjects-commencing-either-boosted-atazanavir-with-truvad-130069https://curecurrent.com/trials/hiv-expression-in-patients-with-low-viral-load-on-highly-active-antiretroviral-therapy-haart-130070https://curecurrent.com/trials/providing-online-counseling-for-home-based-hiv-testing-with-transgender-youth-130071https://curecurrent.com/trials/switching-to-a-fixed-dose-combination-of-bictegravir-emtricitabine-tenofovir-alafenamide-b-f-taf-in-hiv-1-infected-margi-130072https://curecurrent.com/trials/development-and-piloting-of-a-just-in-time-personalized-hiv-prevention-intervention-for-youth-experiencing-homelessness-130073https://curecurrent.com/trials/a-mobile-phone-game-to-prevent-hiv-among-young-africans-130074https://curecurrent.com/trials/optimizing-hiv-virologic-outcomes-for-pregnant-women-in-uganda-130075https://curecurrent.com/trials/puerto-rico-cuidalos-parent-adolescent-program-130076https://curecurrent.com/trials/steering-together-in-a-new-direction-reducing-the-risk-of-hiv-std-among-african-american-men-130077https://curecurrent.com/trials/doxorubicin-hydrochloride-liposome-and-rituximab-with-combination-chemotherapy-in-treating-patients-with-newly-diagnosed-130078https://curecurrent.com/trials/mechanisms-of-diastolic-dysfunction-among-persons-with-hiv-compared-with-non-hiv-control-subjects-130079https://curecurrent.com/trials/evaluation-of-a-smart-phone-app-based-case-management-model-among-art-naive-hiv-infected-msm-130080https://curecurrent.com/trials/evaluation-of-an-early-childhood-development-intervention-for-hiv-exposed-children-in-cameroon-130081https://curecurrent.com/trials/imquest-iqp-duogel-phase-1-pharmacokinetic-study-130082https://curecurrent.com/trials/dolutegravir-antiretroviral-strategy-to-promote-improvement-and-reduce-drug-exposure-130083https://curecurrent.com/trials/the-raltegravir-and-ribavirin-pharmacokinetics-pk-study-130084https://curecurrent.com/trials/pharmacokinetics-of-bictegravir-in-adults-with-normal-and-impaired-renal-function-130085https://curecurrent.com/trials/redirected-high-affinity-gag-specific-autologous-t-cells-for-hiv-gene-therapy-130086https://curecurrent.com/trials/inducing-immune-quiescence-to-prevent-hiv-infection-in-women-130087https://curecurrent.com/trials/pk-study-of-90-day-use-of-vaginal-rings-containing-dapivirine-and-levonorgestrel-130088https://curecurrent.com/trials/bronchopulmonary-function-in-response-to-azithromycin-treatment-for-chronic-lung-disease-in-hiv-infected-children-130089https://curecurrent.com/trials/nelfinavir-in-recurrent-adenoid-cystic-cancer-of-the-head-and-neck-130090https://curecurrent.com/trials/brief-intervention-for-rural-women-at-high-risk-for-hiv-hcv-130091https://curecurrent.com/trials/hiv-acquired-lipodystrophy-hal-classification-measurement-and-fat-response-to-thiazolidinedione-tzd-pioglitazone-130092https://curecurrent.com/trials/er-niacin-laropiprant-impact-on-cardiovascular-markers-and-atheroprogression-in-hiv-infected-individuals-on-cart-130093https://curecurrent.com/trials/pilot-trial-of-the-effect-of-vorinostat-and-ags-004-on-persistent-hiv-1-infection-130094https://curecurrent.com/trials/phase-i-study-of-hiv-1-antigen-expanded-specific-t-cell-therapy-130095https://curecurrent.com/trials/increasing-social-support-to-improve-hiv-care-engagement-and-adherence-in-st-petersburg-russia-130096https://curecurrent.com/trials/immune-reconstitution-syndrome-in-hiv-infected-patients-taking-antiretroviral-therapy-130097https://curecurrent.com/trials/project-yes-youth-engaging-for-success-130098https://curecurrent.com/trials/path-for-triples-study-medication-and-lifestyle-adherence-for-hiv-patients-130099https://curecurrent.com/trials/a-smoking-cessation-trial-in-hiv-infected-patients-in-south-africa-130100https://curecurrent.com/trials/quantiferon-gold-test-for-detecting-tuberculosis-tb-infection-in-hiv-aids-patients-in-south-africa-130101https://curecurrent.com/trials/impact-of-cotrimoxazole-use-in-immunocompetent-hiv-patients-on-carriage-of-antimicrobial-resistant-bacteria-130102https://curecurrent.com/trials/neural-correlates-of-working-memory-training-for-hiv-patients-130103https://curecurrent.com/trials/reducing-self-stigma-in-persons-with-hiv-and-drug-use-disorders-in-primary-health-care-settings-130104https://curecurrent.com/trials/internet-based-hiv-sti-prevention-for-young-msm-receiving-hiv-testing-130105https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-of-raltegravir-mk-0518-in-healthy-japanese-male-participants-mk-0518-851-130106https://curecurrent.com/trials/hiv-adherence-bottle-intervention-trial-130107https://curecurrent.com/trials/dose-ranging-study-to-evaluate-the-safety-immunogenicity-of-a-hiv-vaccine-732461-in-healthy-hiv-seronegative-volunteers-130108https://curecurrent.com/trials/a-drug-safety-and-dose-exploratory-clinical-study-of-azvudine-tablets-in-patients-who-have-not-received-anti-hiv-treatme-130109https://curecurrent.com/trials/the-impact-and-cost-effectiveness-of-safer-conception-strategies-for-hiv-discordant-couples-safer-130110https://curecurrent.com/trials/dual-therapy-with-raltegravir-and-darunavir-ritonavir-in-hiv-infected-patients-130111https://curecurrent.com/trials/mitochondria-in-hiv-and-aging-mito-130112https://curecurrent.com/trials/altair-alternative-antiretroviral-strategies-a-comparison-of-three-initial-regimens-130113https://curecurrent.com/trials/hiv-upbeat-understanding-the-pathology-of-bone-disease-in-hiv-infected-patients-130114https://curecurrent.com/trials/analytical-treatment-interruption-in-hiv-positive-patients-130115https://curecurrent.com/trials/open-label-study-to-evaluate-chronic-hepatitis-c-treatment-in-latino-subjects-with-and-without-hiv-co-infection-130116https://curecurrent.com/trials/application-of-oral-bacteriotherapy-to-promote-anal-hpv-clearance-in-hiv-positive-individuals-130117https://curecurrent.com/trials/safety-and-efficacy-of-e-c-f-tdf-versus-rtv-boosted-atv-plus-ftc-tdf-in-hiv-1-infected-antiretroviral-treatment-naive-wo-130118https://curecurrent.com/trials/treatment-of-pd-1-inhibitor-in-aids-associated-pml-130119https://curecurrent.com/trials/study-of-autologous-t-cells-genetically-modified-at-the-ccr5-gene-by-zinc-finger-nucleases-in-hiv-infected-subjects-130120https://curecurrent.com/trials/a-smartphone-application-to-support-physical-activity-in-hiv-infected-people-130121https://curecurrent.com/trials/study-of-immune-responses-induced-by-a-hiv-vaccine-130122https://curecurrent.com/trials/using-telmisartan-with-art-during-acute-hiv-infection-to-reduce-the-cns-reservoirs-of-hiv-and-lymph-node-fibrosis-130123https://curecurrent.com/trials/hiv-and-sexually-transmitted-infection-prevention-intervention-in-the-northwest-territories-130124https://curecurrent.com/trials/facial-lipoatrophy-correction-experience-with-sculptra-faces-study-130125https://curecurrent.com/trials/varenicline-for-nicotine-dependence-among-those-with-hiv-aids-130126https://curecurrent.com/trials/proviral-dna-as-a-target-for-hiv-1-resistance-analysis-130127https://curecurrent.com/trials/safety-pk-and-antiviral-activity-of-pgt121-monoclonal-antibody-in-hiv-uninfected-and-hiv-infected-adults-130128https://curecurrent.com/trials/body-compartment-pk-for-new-hiv-pre-exposure-prophylaxis-modalities-130129https://curecurrent.com/trials/the-impact-on-linkage-to-care-of-an-alternative-hepatitis-c-screening-method-in-pwid-130130https://curecurrent.com/trials/antiretroviral-therapy-adherence-and-secondary-prevention-of-human-immunodeficiency-virus-130131https://curecurrent.com/trials/trimethoprim-sulfamethoxazole-combined-with-caspofungin-as-first-line-therapy-in-pcp-130132https://curecurrent.com/trials/vicriviroc-a-ccr5-inhibitor-added-to-an-optimized-antiretroviral-therapy-for-previously-treated-hiv-victor-e2-study-p042-130133https://curecurrent.com/trials/the-st-marys-and-the-mater-switch-study-130134https://curecurrent.com/trials/women-s-improvement-of-sexual-health-wish-demonstration-project-130135https://curecurrent.com/trials/the-effectiveness-of-a-relaxation-technique-on-the-quality-of-life-and-symptoms-in-people-living-with-hiv-130136https://curecurrent.com/trials/human-immunodeficiency-virus-hiv-arterial-dysfunction-lipids-lovaza-halo-trial-130137https://curecurrent.com/trials/drug-exposure-registry-for-gsk2248761-an-investigational-nnrti-130138https://curecurrent.com/trials/effect-of-an-electronic-cognitive-aid-versus-static-cognitive-aid-on-the-management-of-a-simulated-crisis-130139https://curecurrent.com/trials/acupuncture-moxibustion-for-peripheral-neuropathy-in-hiv-130140https://curecurrent.com/trials/crush-prep-for-women-project-130141https://curecurrent.com/trials/using-mobile-technology-and-incentives-with-men-who-have-sex-with-men-and-transgender-women-for-hiv-prevention-130142https://curecurrent.com/trials/study-to-improve-survival-among-hiv-exposed-infants-in-botswana-130143https://curecurrent.com/trials/storytelling-narrative-communication-intervention-for-smoking-cessation-in-women-living-with-hiv-130144https://curecurrent.com/trials/brief-alcohol-intervention-for-hiv-infected-men-who-have-sex-with-men-msm-in-a-primary-care-setting-130145https://curecurrent.com/trials/observational-study-of-hiv-infection-in-participants-of-seroconvert-during-dapivirine-vaginal-ring-trials-130146https://curecurrent.com/trials/a-study-to-compare-the-relative-bioavailability-of-two-different-formulations-of-gsk3640254-130147https://curecurrent.com/trials/hiv-computerized-depression-therapy-cognition-130148https://curecurrent.com/trials/targeted-anticoagulation-therapy-to-reduce-inflammation-and-cellular-activation-in-long-term-hiv-disease-130149https://curecurrent.com/trials/timing-of-referral-to-adherence-clubs-for-antiretroviral-therapy-130150https://curecurrent.com/trials/efficacy-and-safety-study-of-darunavir-for-the-treatment-of-hiv-aids-130151https://curecurrent.com/trials/youth-mhealth-adherence-intervention-for-hiv-ymsm-130152https://curecurrent.com/trials/optimization-of-darunavir-therapy-and-dosage-recommendations-130153https://curecurrent.com/trials/dolutegravir-plus-2-nrtis-in-treatment-na-ve-hiv-2-infected-subjects-130154https://curecurrent.com/trials/redirected-mazf-cd4-autologous-t-cells-for-hiv-gene-therapy-130155https://curecurrent.com/trials/evaluation-of-a-simplified-strategy-for-the-long-term-management-of-hiv-infection-simpl-hiv-130156https://curecurrent.com/trials/an-hiv-vaccine-trial-in-individuals-who-started-art-during-primary-or-chronic-infection-130157https://curecurrent.com/trials/impact-of-in-utero-and-breastfeeding-exposure-to-tenofovir-on-renal-function-in-hiv-exposed-uninfected-children-130158https://curecurrent.com/trials/optimizing-hiv-prep-through-shared-decision-making-130159https://curecurrent.com/trials/new-era-study-treatment-with-multi-drug-class-mdc-haart-in-hiv-infected-patients-130160https://curecurrent.com/trials/elvitegravir-cobicistat-emtricitabine-tenofovir-alafenamide-as-maintenance-treatment-for-hiv-hbv-coinfection-130161https://curecurrent.com/trials/regional-multicenter-study-to-evaluate-tolerability-and-efficacy-of-taf-ftc-rpv-combination-odefsey-in-prevention-of-sex-130162https://curecurrent.com/trials/crowdsourcing-a-public-health-campaign-130163https://curecurrent.com/trials/love-sex-choices-a-web-series-on-mobile-devices-to-reduce-black-women-s-hiv-risk-130164https://curecurrent.com/trials/rpv-drv-cobi-dual-therapy-in-subjects-with-hiv-controlled-infection-130165https://curecurrent.com/trials/safety-and-immunogenicity-study-of-aeras-456-vaccine-for-tuberculosis-130166https://curecurrent.com/trials/mediterranean-diet-and-bacterial-translocation-and-immune-activation-in-patients-with-hiv-130167https://curecurrent.com/trials/a-randomized-controlled-trial-of-hiv-testing-and-linkage-to-care-at-community-corrections-130168https://curecurrent.com/trials/quality-of-life-of-taiwan-people-living-with-hiv-130169https://curecurrent.com/trials/the-evidence-for-contraceptive-options-and-hiv-outcomes-trial-130170https://curecurrent.com/trials/church-based-hiv-screening-taking-it-to-the-pews-130171https://curecurrent.com/trials/clinical-epidemiology-cohort-study-for-patient-living-with-hiv-130172https://curecurrent.com/trials/prevalence-of-cutaneous-autoimmune-phenomena-in-hiv-infected-patients-130173https://curecurrent.com/trials/impact-of-hepatitis-c-therapy-and-bone-health-130174https://curecurrent.com/trials/mylife-mystyle-evaluation-project-130175https://curecurrent.com/trials/the-i-score-study-developing-a-new-patient-reported-tool-for-the-routine-hiv-care-of-patients-on-antiretroviral-therapy-130176https://curecurrent.com/trials/evaluation-of-pre-exposure-prophylaxis-for-high-risk-adolescent-girls-and-young-women-130177https://curecurrent.com/trials/a-pragmatic-pilot-study-of-cognitive-behavioural-therapy-for-insomnia-among-people-living-with-hiv-130178https://curecurrent.com/trials/a-phase-2a-evaluation-of-the-safety-tolerability-pharmacokinetics-efficacy-of-clofazimine-cfz-in-cryptosporidiosis-130179https://curecurrent.com/trials/cerebrospinal-fluid-csf-raltegravir-substudy-130180https://curecurrent.com/trials/open-feasibility-study-130181https://curecurrent.com/trials/assessing-the-effectiveness-and-feasibility-of-voluntary-assisted-partner-notification-services-130182https://curecurrent.com/trials/coronary-artery-disease-cad-in-suppressed-hiv-infected-130183https://curecurrent.com/trials/innovations-in-hiv-testing-130184https://curecurrent.com/trials/dolutegravir-plus-tenofovir-lamivudine-or-emtricitabine-in-hiv-1-infected-transgender-women-130185https://curecurrent.com/trials/tenofovir-renal-toxicity-and-glomerular-filtration-rate-gfr-validation-130186https://curecurrent.com/trials/trial-of-vitamin-d-in-hiv-progression-130187https://curecurrent.com/trials/the-kanyakla-study-a-microclinic-social-network-intervention-for-promoting-engagement-and-retention-in-hiv-care-130188https://curecurrent.com/trials/using-values-to-enhance-inmates-response-to-substance-use-and-hiv-risk-feedback-130189https://curecurrent.com/trials/infant-peri-exposure-prophylaxis-to-prevent-hiv-1-transmission-by-breastfeeding-mechanisms-safety-130190https://curecurrent.com/trials/calcium-and-high-dose-vitamin-d-supplementation-on-bone-mineral-density-among-hiv-infected-children-and-adolescents-130191https://curecurrent.com/trials/epidemiology-of-congenital-cytomegalovirus-in-a-high-hiv-prevalence-setting-south-africa-130192https://curecurrent.com/trials/comparing-pi-based-to-a-nnrti-based-art-for-clearance-of-plasmodium-falciparum-parasitemia-in-hiv-infected-130193https://curecurrent.com/trials/addressing-psychosocial-comorbidities-in-hiv-treatment-and-prevention-130194https://curecurrent.com/trials/smoking-cessation-intervention-for-women-living-with-hiv-130195https://curecurrent.com/trials/manicaland-cash-transfer-trial-for-children-in-zimbabwe-130196https://curecurrent.com/trials/effects-of-losartan-and-antiretroviral-regimen-containing-raltegravir-in-fibrosis-inflammation-mediators-cardiovascular-130197https://curecurrent.com/trials/safety-and-efficacy-of-rifabutin-in-hiv-patients-130198https://curecurrent.com/trials/ped-hiv-echo-study-kenya-130199https://curecurrent.com/trials/gsk1349572-hepatic-impairment-study-130200https://curecurrent.com/trials/simplified-antiviral-treatment-strategy-for-hepatitis-c-in-ukraine-130201https://curecurrent.com/trials/evaluation-study-of-rdts-detecting-antibodies-against-hcv-130202https://curecurrent.com/trials/simplified-antiviral-treatment-strategy-for-hepatitis-c-in-myanmar-130203https://curecurrent.com/trials/safety-and-immunogenicity-of-a-vaccine-dendritic-cell-based-pulsed-with-autologous-heat-inactivated-in-hiv-1-infected-pa-130204https://curecurrent.com/trials/neurocognitive-function-improvement-after-switching-from-efavirenz-to-rilpivirine-130205https://curecurrent.com/trials/hiv-dna-dynamics-in-hiv-monoinfected-or-hiv-hcv-coinfected-patients-130206https://curecurrent.com/trials/study-of-topical-abi-1968-in-subjects-with-precancerous-anal-lesions-resulting-from-human-papillomavirus-hpv-infection-130207https://curecurrent.com/trials/itraconazole-pharmacokinetic-with-and-without-efavirenz-using-the-capsule-formulation-as-part-of-talaromycosis-treatment-130208https://curecurrent.com/trials/atazanavir-r-lamivudine-dual-therapy-130209https://curecurrent.com/trials/safety-pk-and-pd-study-of-ivrs-releasing-tfv-and-lng-130210https://curecurrent.com/trials/bioavailability-study-of-10-milligram-mg-and-5-mg-tablets-versus-conventional-tablets-of-dolutegravir-130211https://curecurrent.com/trials/immune-enhancement-for-immunological-non-responders-to-art-130212https://curecurrent.com/trials/multicenter-aids-cohort-study-macs-130213https://curecurrent.com/trials/a-dose-ranging-study-to-compare-doravirine-mk-1439-plus-truvada-versus-efavirenz-plus-truvada-in-human-immunodeficiency-130214https://curecurrent.com/trials/women-s-interagency-hiv-study-wihs-130215https://curecurrent.com/trials/mechanisms-of-lipodystrophy-in-hiv-infected-pateints-130216https://curecurrent.com/trials/study-of-ddt-and-loss-of-clinically-recognized-pregnancies-in-south-africa-130217https://curecurrent.com/trials/development-of-a-tailored-hiv-prevention-intervention-for-young-men-130218https://curecurrent.com/trials/the-solve-it-national-randomized-trial-130219https://curecurrent.com/trials/safety-pk-and-pd-study-of-a-vaginal-insert-containing-taf-and-evg-130220https://curecurrent.com/trials/integrated-care-centers-to-improve-hiv-outcomes-in-vulnerable-indian-populations-130221https://curecurrent.com/trials/use-of-incentives-to-retain-drug-users-in-hiv-therapy-130222https://curecurrent.com/trials/activity-of-mk-8504-in-anti-retroviral-na-ve-human-immunodeficiency-virus-1-hiv-1-infected-participants-mk-8504-002-130223https://curecurrent.com/trials/bioequivalence-study-of-a-fixed-dose-combination-fdc-of-dolutegravir-dtg-and-rilpivirine-rpv-130224https://curecurrent.com/trials/bk-virus-in-salivary-gland-disease-treating-the-potential-etiologic-agent-130225https://curecurrent.com/trials/effectiveness-of-communication-technology-in-disseminating-hiv-prevention-training-to-non-governmental-organizations-130226https://curecurrent.com/trials/prep-demonstration-study-in-swaziland-130227https://curecurrent.com/trials/social-network-intervention-to-engage-out-of-care-plh-into-treatment-130228https://curecurrent.com/trials/mhealth-and-hiv-self-testing-130229https://curecurrent.com/trials/harm-reduction-program-for-informal-prep-users-in-a-community-based-setting-seguiprep-130230https://curecurrent.com/trials/dutch-acute-hcv-in-hiv-study-dahhs-2-grazoprevir-elbasvir-for-acute-hcv-130231https://curecurrent.com/trials/readiness-to-disclose-mother-s-hiv-diagnosis-to-their-children-in-beijing-china-130232https://curecurrent.com/trials/demonstration-project-on-the-feasibility-to-implement-prep-in-msm-and-tg-women-130233https://curecurrent.com/trials/the-influence-of-psychological-interventions-upon-disease-progression-in-hiv-infected-patients-receiving-no-medication-130234https://curecurrent.com/trials/cerebral-toxoplasmosis-and-aids-130235https://curecurrent.com/trials/developing-and-examining-evidenced-based-hiv-testing-messages-130236https://curecurrent.com/trials/anrs12373-gundo-so-evaluation-of-an-empowerment-program-for-wlhiv-in-mali-130237https://curecurrent.com/trials/a-cohort-study-to-assess-sustained-immunogenicity-to-qhpv-vaccine-among-hiv-infected-girls-and-boys-age-9-14-years-130238https://curecurrent.com/trials/safety-and-pharmacokinetic-study-of-hiv-prophylaxis-using-antiretroviral-intravaginal-rings-in-healthy-women-130239https://curecurrent.com/trials/pk-study-of-rifampicin-interactions-with-dmpa-and-efavirenz-in-tb-130240https://curecurrent.com/trials/understanding-substance-use-and-incident-hiv-sti-among-young-black-msm-130241https://curecurrent.com/trials/effects-of-doravirine-mk-1439-on-methadone-pharmacokinetics-in-methadone-maintained-participants-mk-1439-045-130242https://curecurrent.com/trials/evaluating-accuracy-impact-and-operational-challenges-of-genexpert-use-for-tb-case-finding-among-hiv-infected-persons-130243https://curecurrent.com/trials/drug-interaction-study-between-gsk1349572-and-tipranavir-ritonavir-in-healthy-volunteers-130244https://curecurrent.com/trials/safety-of-and-immune-response-to-vaccination-with-2-experimental-hiv-vaccines-in-healthy-adults-130245https://curecurrent.com/trials/safety-of-and-immune-response-to-a-dna-hiv-vaccine-boosted-with-a-modified-vaccinia-hiv-vaccine-and-protein-hiv-vaccine-130246https://curecurrent.com/trials/safety-and-immune-response-to-a-clade-c-dna-hiv-vaccine-130247https://curecurrent.com/trials/bococizumab-hiv-evaluation-b-hive-study-130248https://curecurrent.com/trials/safety-and-efficacy-of-allogenic-adoptive-immune-therapy-for-immune-reconstitution-in-chronic-hiv-1-infected-patients-130249https://curecurrent.com/trials/peer-leaders-as-hiv-risk-reduction-change-agents-among-injection-drug-users-idus-in-ukraine-130250https://curecurrent.com/trials/nonalcoholic-steatohepatitis-in-hiv-mono-infection-exploring-non-invasive-methods-for-diagnosis-and-the-therapeutic-role-130251https://curecurrent.com/trials/combination-vaccination-before-hiv-treatment-interruption-130252https://curecurrent.com/trials/a-study-of-the-safety-and-effectiveness-of-simeprevir-and-sofosbuvir-for-patients-with-hiv-and-hepatitis-c-130253https://curecurrent.com/trials/validation-of-rapid-tests-for-the-serological-diagnosis-of-hiv-in-9-to-24-months-old-children-130254https://curecurrent.com/trials/role-of-the-balano-preputial-furrow-s-microbiota-in-circumcised-patients-or-not-in-the-acquisition-or-transmission-of-hi-130255https://curecurrent.com/trials/utilizing-the-hitsystem-for-optimizing-paediatric-art-retention-and-adherence-in-western-nyanza-province-kenya-130256https://curecurrent.com/trials/usability-study-of-a-self-test-prototype-for-human-immunodeficiency-virus-hiv-screening-130257https://curecurrent.com/trials/lopinavir-r-lamivudine-abacavir-as-an-easy-to-use-paediatric-formulation-130258https://curecurrent.com/trials/the-effectiveness-of-dual-therapy-lopinavir-ritonavir-lamivudine-in-treatment-experienced-hiv-infected-patients-in-the-r-130259https://curecurrent.com/trials/reconstitution-of-hiv-specific-immunity-against-hiv-130260https://curecurrent.com/trials/effect-of-high-dose-vitamin-d-supplementation-on-hiv-latency-130261https://curecurrent.com/trials/casa-care-and-support-access-in-hiv-disease-130262https://curecurrent.com/trials/hcv-hiv-co-infected-patient-cohort-in-thailand-130263https://curecurrent.com/trials/protease-inhibitors-and-combined-oral-contraceptive-pharmacokinetics-and-pharmacodynamics-130264https://curecurrent.com/trials/do-ccr5-antagonists-improve-the-overall-survival-of-patients-with-aids-related-progressive-multifocal-leucoencephalopath-130265https://curecurrent.com/trials/lotto-to-link-study-a-prospective-interventional-randomized-study-of-conditional-incentives-130266https://curecurrent.com/trials/autonomic-neuropathy-gi-motility-and-inflammation-in-hiv-130267https://curecurrent.com/trials/immunogenicity-and-persistence-of-hepatitis-b-vaccination-in-hiv-infected-patients-130268https://curecurrent.com/trials/youth-drug-abuse-prevention-in-kazakhstan-130269https://curecurrent.com/trials/a-couple-based-hiv-prevention-intervention-to-promote-hiv-protection-among-latino-male-couples-130270https://curecurrent.com/trials/prospective-study-of-lopinavir-based-art-for-hiv-infected-children-globally-living-study-130271https://curecurrent.com/trials/phase-ib-study-of-safety-tolerability-and-pharmacokinetics-of-elpida-once-weekly-in-healthy-volunteers-130272https://curecurrent.com/trials/evaluation-of-a-short-version-computerized-test-for-processing-speed-to-detect-cognitive-disorders-in-hiv-patients-130273https://curecurrent.com/trials/hi-4-tu-study-health-improvement-for-teen-ugandans-study-130274https://curecurrent.com/trials/pharmacokinetic-study-of-super-boosted-lopinavir-ritonavir-given-with-rifampin-130275https://curecurrent.com/trials/protease-inhibitors-to-reduce-malaria-morbidity-in-hiv-infected-pregnant-women-130276https://curecurrent.com/trials/therapeutic-approaches-to-haart-induced-lipodystrophy-130277https://curecurrent.com/trials/switching-tdf-ftc-efv-to-tdf-ftc-rpv-vs-continuing-tdf-ftc-efv-in-hiv-patients-with-complete-virological-suppression-130278https://curecurrent.com/trials/nurse-case-management-to-improve-hepatitis-c-care-in-hiv-co-infection-130279https://curecurrent.com/trials/brief-personalized-feedback-intervention-for-hazardous-drinking-in-an-hiv-clinic-130280https://curecurrent.com/trials/researching-alveolar-macrophage-improvements-with-supplements-in-hiv-130281https://curecurrent.com/trials/randomized-controlled-trial-of-interpersonal-psychotherapy-for-depression-and-ptsd-among-hiv-women-in-kenya-130282https://curecurrent.com/trials/modulation-of-monocyte-activation-by-atorvastatin-in-hiv-infection-130283https://curecurrent.com/trials/il-23-il-12-imbalance-and-t-lymphocyte-polarization-in-hiv-infection-130284https://curecurrent.com/trials/people-living-with-hiv-aids-nitrate-endotelial-function-arterial-stiffness-and-skeletal-muscle-oxygenation-130285https://curecurrent.com/trials/antiretroviral-therapy-for-acute-hiv-infection-130286https://curecurrent.com/trials/hiv-vaccine-trial-in-thai-adults-130287https://curecurrent.com/trials/a-prospective-open-label-trial-of-two-abc-3tc-based-regimens-in-late-presenter-na-ve-patients-cd4-200-cells-l-130288https://curecurrent.com/trials/interferon-alpha-2b-intensification-in-hiv-positive-individuals-on-antiretroviral-therapy-130289https://curecurrent.com/trials/hiv-counseling-intervention-for-methadone-maintained-patients-2-130290https://curecurrent.com/trials/brief-electronic-intervention-for-heavy-drinking-and-sex-risk-among-msm-seeking-hiv-testing-130291https://curecurrent.com/trials/intermittent-naltrexone-among-polysubstance-users-130292https://curecurrent.com/trials/effect-of-xpert-mtb-rif-on-patient-outcomes-130293https://curecurrent.com/trials/isoniazid-prophylaxis-with-concomitant-cotrimoxazole-in-hiv-infected-children-130294https://curecurrent.com/trials/pre-exposure-prophylaxis-to-prevent-hiv-1-acquisition-within-hiv-1-discordant-couples-130295https://curecurrent.com/trials/evaluating-a-real-time-remote-monitoring-system-for-home-based-hiv-testing-130296https://curecurrent.com/trials/an-integrated-hiv-prevention-model-for-african-american-mothers-and-daughters-130297https://curecurrent.com/trials/study-of-recently-hiv-infected-men-and-transmission-behaviors-130298https://curecurrent.com/trials/my-smart-age-with-hiv-smartphone-self-assessment-of-frailty-130299https://curecurrent.com/trials/effectiveness-of-an-hiv-adapted-imci-training-and-supervision-programme-for-community-health-workers-130300https://curecurrent.com/trials/aging-with-hiv-at-younger-vs-older-age-a-diverse-population-with-distinct-comorbidity-profiles-130301https://curecurrent.com/trials/hiv-prevention-toolkit-for-hiv-negative-male-couples-130302https://curecurrent.com/trials/decision-support-intervention-adapted-for-hiv-pre-exposure-prophylaxis-for-adoption-and-adherence-for-black-canadians-130303https://curecurrent.com/trials/dipyridamole-for-immune-activation-in-hiv-130304https://curecurrent.com/trials/safety-tolerability-and-immunogenicity-induced-by-the-thv01-treatment-in-patients-infected-with-hiv-1-clade-b-and-treate-130305https://curecurrent.com/trials/comparing-daily-vs-intermittent-regimen-of-att-in-hiv-with-pulmonary-tuberculosis-130306https://curecurrent.com/trials/neurocognitive-effects-of-buprenorphine-among-hiv-and-hiv-opioid-users-130307https://curecurrent.com/trials/retain-retaining-opioid-users-entering-medication-assisted-treatment-and-encouraging-hcv-hiv-testing-130308https://curecurrent.com/trials/a-phase-i-study-of-t-cells-genetically-modified-at-the-ccr5-gene-by-zinc-finger-nucleases-sb-728mr-in-hiv-infected-patie-130309https://curecurrent.com/trials/evaluation-of-safety-and-immunogenicity-of-meningococcal-b-and-meningococcal-acwy-vaccine-in-at-risk-population-130310https://curecurrent.com/trials/viral-and-host-factors-in-the-transmission-and-pathogenesis-of-hiv-130311https://curecurrent.com/trials/awaits-a-web-based-e-health-application-for-active-illicit-opioid-users-130312https://curecurrent.com/trials/accelerated-resolution-therapy-for-hiv-positive-african-caribbean-and-black-130313https://curecurrent.com/trials/expanded-access-protocol-of-ata230-third-party-donor-derived-cmv-ctls-for-the-treatment-of-cmv-viremia-or-disease-130314https://curecurrent.com/trials/evaluation-of-renal-function-efficacy-and-safety-when-switching-from-tenofovir-emtricitabine-plus-a-protease-inhibitor-r-130315https://curecurrent.com/trials/efficacy-trial-of-ambisome-given-alone-and-ambisome-given-in-combination-with-miltefosine-for-the-treatment-of-vl-hiv-po-130316https://curecurrent.com/trials/study-to-evaluate-safety-immunogenicity-and-efficacy-of-pfspz-vaccine-in-hiv-negative-and-hiv-positive-tanzanian-adults-130317https://curecurrent.com/trials/clinical-evaluation-of-adjusted-doses-of-darunavir-ritonavir-with-rifampicin-in-hiv-infected-volunteers-130318https://curecurrent.com/trials/moringa-oleifera-antiretroviral-pharmacokinetic-drug-interaction-130319https://curecurrent.com/trials/5-years-follow-up-evaluation-of-deterioration-kidney-biomarkers-of-hiv-patients-130320https://curecurrent.com/trials/darunavir-and-rilpivirine-interactions-with-levonorgestrel-implant-130321https://curecurrent.com/trials/darunavir-and-rilpivirine-interactions-with-etonogestrel-contraceptive-implant-130322https://curecurrent.com/trials/renal-endocrine-and-bone-changes-in-response-to-ftc-tdf-in-uninfected-young-men-who-have-sex-with-men-ymsm-130323https://curecurrent.com/trials/vitamin-d-absorption-in-hiv-infected-young-adults-being-treated-with-tenofovir-containing-cart-130324https://curecurrent.com/trials/feasibility-of-short-term-prep-uptake-for-msm-with-episodic-high-risk-for-hiv-130325https://curecurrent.com/trials/healthy-choices-to-promote-health-and-reduce-risk-in-hiv-infected-youth-130326https://curecurrent.com/trials/mvip-use-of-mhealth-technology-for-supporting-symptom-management-in-underserved-persons-living-with-hiv-130327https://curecurrent.com/trials/fish-oil-for-hiv-related-inflamm-aging-and-immune-senescence-130328https://curecurrent.com/trials/a-pilot-study-to-examine-the-feasibility-and-effect-of-tumor-necrosis-factor-tnf-inhibition-on-hiv-disease-130329https://curecurrent.com/trials/nelfinavir-and-m8-drug-level-monitoring-in-hiv-1-infection-130330https://curecurrent.com/trials/study-in-healthy-adults-to-evaluate-gene-activation-after-vaccination-with-glaxosmithkline-gsk-biologicals-candidate-tub-130331https://curecurrent.com/trials/reducing-heavy-drinking-to-optimize-hiv-aids-treatment-and-prevention-130332https://curecurrent.com/trials/resistance-training-in-people-living-with-hiv-aids-130333https://curecurrent.com/trials/comparing-treatments-for-hiv-infected-opioid-and-alcohol-users-in-an-integrated-care-effectiveness-study-130334https://curecurrent.com/trials/get-ready-and-empowered-about-treatment-130335https://curecurrent.com/trials/study-of-the-efficacy-and-security-of-ibandronate-for-osteoporosis-treatment-in-a-hiv-infected-patients-cohort-130336https://curecurrent.com/trials/overcoming-barriers-to-hiv-aids-care-and-art-initiation-130337https://curecurrent.com/trials/tasp-in-correctional-facilities-130338https://curecurrent.com/trials/phase-2a-id93-gla-se-vaccine-trial-in-tb-patients-after-treatment-completion-130339https://curecurrent.com/trials/real-world-insights-of-people-with-human-immunodeficiency-virus-hiv-infection-130340https://curecurrent.com/trials/safety-and-efficacy-of-rifabutin-in-patients-for-non-hiv-patients-130341https://curecurrent.com/trials/vitamin-d-hiv-study-on-postmenopausal-women-130342https://curecurrent.com/trials/computerized-cognitive-rehabilitation-in-ugandan-children-with-hiv-130343https://curecurrent.com/trials/attenuation-of-d-dimer-using-vorapaxar-to-target-inflammatory-and-coagulation-endpoints-130344https://curecurrent.com/trials/efficacy-of-sms-to-improve-early-retention-in-hiv-care-for-plwh-in-lima-130345https://curecurrent.com/trials/youth-power-action-feasibility-study-of-online-support-group-intervention-among-adolescents-living-with-hiv-in-nigeria-130346https://curecurrent.com/trials/risky-decision-making-in-methamphetamine-users-the-role-of-opioid-blockade-130347https://curecurrent.com/trials/oxytocin-hiv-meth-study-130348https://curecurrent.com/trials/reducing-the-burden-of-malaria-in-hiv-infected-pregnant-women-and-their-hiv-exposed-children-promote-bc2-130349https://curecurrent.com/trials/family-planning-service-delivery-integration-for-hiv-positive-and-at-risk-women-in-botswana-a-hybrid-type-2-clinical-int-130350https://curecurrent.com/trials/black-men-evolving-behavioral-hiv-prevention-intervention-for-black-msm-130351https://curecurrent.com/trials/a-field-experiment-to-assess-the-demand-for-hiv-self-tests-in-zimbabwe-130352https://curecurrent.com/trials/a-study-of-the-neurological-effects-of-adding-maraviroc-to-haart-regimen-in-patients-with-hiv-handmac-130353https://curecurrent.com/trials/drug-drug-interaction-study-asp2151-and-ritonavir-130354https://curecurrent.com/trials/preventing-cigarette-use-among-urban-youth-via-an-m-health-primary-care-preventive-intervention-130355https://curecurrent.com/trials/outcomes-in-liver-disease-patient-with-and-without-hiv-co-infection-sub-study-2-hcv-treatment-health-related-quality-130356https://curecurrent.com/trials/rapid-build-of-hiv-related-protective-barriers-130357https://curecurrent.com/trials/mental-ability-challenge-study-in-adults-with-and-without-hiv-130358https://curecurrent.com/trials/hiv-physician-s-survey-130359https://curecurrent.com/trials/hiv-testing-in-pregnant-women-evaluating-an-opt-out-testing-strategy-130360https://curecurrent.com/trials/fetal-hiv-transmission-risk-and-duration-of-membrane-rupture-130361https://curecurrent.com/trials/understanding-hiv-susceptibility-in-the-female-genital-tract-130362https://curecurrent.com/trials/implementing-a-comprehensive-prevention-of-mother-to-child-transmission-of-hiv-program-for-south-african-couples-130363https://curecurrent.com/trials/bioequivalence-study-of-fixed-dose-versus-single-entities-of-dolutegravir-and-lamivudine-130364https://curecurrent.com/trials/safer-sex-program-for-young-african-american-men-130365https://curecurrent.com/trials/a-study-to-evaluate-the-pharmacokinetics-of-an-oral-contraceptive-when-co-administered-with-gsk2248761-in-healthy-adult-130366https://curecurrent.com/trials/a-study-of-selumetinib-in-patients-with-kaposi-s-sarcoma-130367https://curecurrent.com/trials/sofosbuvir-and-daclatasvir-for-treating-hepatitis-c-in-200-patients-co-infected-with-human-immunodeficiency-virus-130368https://curecurrent.com/trials/same-day-art-initiation-versus-standard-of-care-after-positive-hiv-test-result-in-rural-lesotho-130369https://curecurrent.com/trials/a-drug-interaction-study-to-assess-the-pharmacokinetics-of-narlaprevir-and-antiretroviral-drugs-130370https://curecurrent.com/trials/prospective-evaluation-of-hiv-patients-using-non-invasive-methods-for-estimation-of-liver-fibrosis-and-steatosis-130371https://curecurrent.com/trials/evaluating-a-microfinance-intervention-for-vulnerable-women-in-kazakhstan-130372https://curecurrent.com/trials/evaluation-of-compliance-with-treatment-by-genvoya-in-hiv-post-exposure-prophylaxis-130373https://curecurrent.com/trials/raltegravir-one-thousand-two-hundred-vs-darunavir-cb-in-immnunosupressed-patients-rotdip-study-130374https://curecurrent.com/trials/neuropsyquiatric-evolution-after-introduction-of-raltegravir-qd-in-substitution-of-dolutegravir-near-qd-study-130375https://curecurrent.com/trials/identification-and-quantification-of-hiv-cns-latency-biomarkers-130376https://curecurrent.com/trials/ripe-vs-ripe-plus-n-acetylcysteine-in-patients-with-hiv-tb-co-infection-130377https://curecurrent.com/trials/a-study-of-doravirine-mk-1439-in-human-immunodeficiency-virus-type-1-hiv-1-infected-participants-mk-1439-005-130378https://curecurrent.com/trials/prophylaxis-of-visceral-leishmaniasis-relapses-in-hiv-co-infected-patients-with-pentamidine-a-cohort-study-130379https://curecurrent.com/trials/efficacy-of-gzr-ebr-in-early-chronic-hepatitis-c-in-hiv-hcv-co-infected-patients-130380https://curecurrent.com/trials/integrating-engagement-and-adherence-goals-upon-entry-iengage-to-control-hiv-130381https://curecurrent.com/trials/immunogenicity-and-safety-of-13-valent-pneumococcal-conjugate-vaccine-among-hiv-infected-adults-130382https://curecurrent.com/trials/education-vs-education-plus-intervention-in-hiv-hcv-diagnosis-drive-03-130383https://curecurrent.com/trials/trichomonas-vaginalis-repeat-infections-among-hiv-negative-women-130384https://curecurrent.com/trials/a-study-to-evaluate-the-acceptability-and-preference-for-contraceptive-options-as-proxy-for-hiv-prevention-methods-130385https://curecurrent.com/trials/randomized-placebo-controlled-pilot-trial-of-prebiotics-glutamine-in-hiv-infection-130386https://curecurrent.com/trials/prospective-non-interventional-observational-study-of-use-of-triumeq-and-corresponding-monitoring-measures-in-clinical-p-130387https://curecurrent.com/trials/autologous-t-cells-genetically-modified-at-the-ccr5-gene-by-zinc-finger-nucleases-sb-728-for-hiv-130388https://curecurrent.com/trials/enhanced-housing-placement-assistance-130389https://curecurrent.com/trials/contraceptive-hiv-affecting-risk-in-adolescents-130390https://curecurrent.com/trials/evaluation-of-the-effect-of-late-boost-on-hiv-uninfected-vaccines-from-ev06-trial-130391https://curecurrent.com/trials/study-of-topical-abi-1968-in-subjects-with-precancerous-anal-lesions-resulting-from-human-papillomavirus-hpv-infection-130392https://curecurrent.com/trials/pet-ct-imaging-companion-study-to-actg-a5314-130393https://curecurrent.com/trials/comparative-study-of-human-immunodeficiency-virus-negative-host-talaromyces-between-voriconazole-and-amphotericin-sequen-130394https://curecurrent.com/trials/daily-isoniazid-to-prevent-tuberculosis-in-infants-born-to-mothers-with-hiv-130395https://curecurrent.com/trials/behavioral-economics-field-experiment-in-hiv-testing-130396https://curecurrent.com/trials/regular-hiv-testing-among-at-risk-latino-men-130397https://curecurrent.com/trials/hiv-and-fat-accumulation-130398https://curecurrent.com/trials/phase-4-study-of-dolutegravir-dtg-in-russian-federation-130399https://curecurrent.com/trials/comparative-efficacy-of-an-intensified-re-vaccination-scheme-for-hepatitis-b-virus-infection-among-patients-infected-wit-130400https://curecurrent.com/trials/assessing-the-impact-of-an-educational-hiv-prevention-intervention-in-zambia-130401https://curecurrent.com/trials/prep-for-hbcus-study-2-130402https://curecurrent.com/trials/multicenter-pilot-study-to-define-the-marker-as-an-alternate-for-tropism-assay-130403https://curecurrent.com/trials/effects-of-a-nurse-delivered-cognitive-behaviour-therapy-on-adherence-and-depressive-symptoms-in-hiv-infected-persons-of-130404https://curecurrent.com/trials/trial-of-ibudilast-for-methamphetamine-dependence-130405https://curecurrent.com/trials/evaluation-of-the-safety-and-efficacy-of-reformulated-raltegravir-mk-0518-1200-mg-once-daily-in-combination-with-truvada-130406https://curecurrent.com/trials/effect-of-zinc-and-selenium-supplementation-on-hiv-individuals-on-antiretroviral-treatment-130407https://curecurrent.com/trials/retrospective-analysis-of-the-epidemiological-change-and-determinants-of-prognosis-of-talaromycosisof-human-immunodefici-130408https://curecurrent.com/trials/strategies-for-the-prevention-of-hepatitis-b-among-hiv-infected-patients-in-uganda-130409https://curecurrent.com/trials/a-syndemic-based-intervention-for-msm-with-high-risk-behavior-design-of-a-randomized-controlled-trial-130410https://curecurrent.com/trials/cleac-comparison-of-late-versus-early-antiretroviral-therapy-in-hiv-infected-children-130411https://curecurrent.com/trials/the-yellow-fever-vaccine-immunity-in-hiv-infected-patients-development-of-new-assays-for-virological-and-immunological-m-130412https://curecurrent.com/trials/study-of-single-iv-administration-of-p2g12-130413https://curecurrent.com/trials/safety-and-immunogenicity-of-gsk-biologicals-investigational-malaria-vaccine-in-hiv-infected-infants-and-children-130414https://curecurrent.com/trials/impact-of-different-integrase-inhibitor-based-regimen-on-immune-activation-among-hiv-na-ve-patient-intatti-130415https://curecurrent.com/trials/using-cultural-ceremonies-to-reduce-intimate-partner-violence-and-hiv-transmission-130416https://curecurrent.com/trials/hiv-sti-prevention-for-drug-involved-couples-130417https://curecurrent.com/trials/effects-of-raltegravir-based-regimen-on-platelet-reactivity-platelet-monocyte-aggregation-and-immune-activation-130418https://curecurrent.com/trials/dosimetry-study-of-betalutin-for-treatment-of-relapsed-non-hodgkin-lymphoma-lymrit-37-02-130419https://curecurrent.com/trials/evaluation-of-an-hiv-outreach-program-130420https://curecurrent.com/trials/the-effectiveness-of-a-mobile-interactive-supervised-therapy-mist-intervention-for-improving-adherence-to-hiv-medication-130421https://curecurrent.com/trials/early-access-to-art-for-all-in-swaziland-effects-on-economic-outcomes-130422https://curecurrent.com/trials/rapid-initiation-of-antiretroviral-therapy-to-promote-early-hiv-aids-treatment-in-south-africa-rapit-study-130423https://curecurrent.com/trials/safety-and-immunogenicity-of-imvamune-mva-bn-smallpox-vaccine-in-hiv-infected-patients-130424https://curecurrent.com/trials/evaluating-a-structural-and-behavioral-hiv-risk-reduction-program-for-black-men-130425https://curecurrent.com/trials/hiv-protease-inhibitors-for-the-prevention-of-malaria-in-ugandan-children-130426https://curecurrent.com/trials/gene-modified-hiv-protected-stem-cell-transplant-in-treating-patients-with-hiv-associated-lymphoma-130427https://curecurrent.com/trials/comparison-of-virologic-and-immunologic-responses-to-raltegravir-and-dolutegravir-in-the-gastrointestinal-tract-of-hiv-p-130428https://curecurrent.com/trials/the-use-of-nutropin-depot-in-hiv-infected-adult-males-130429https://curecurrent.com/trials/healthy-activities-for-prize-incentives-130430https://curecurrent.com/trials/optimization-of-the-ex-vivo-challenge-reproductive-infections-and-contraception-130431https://curecurrent.com/trials/efficacy-and-tolerability-of-grazoprevir-and-elbasvir-in-patients-with-chronic-genotype-1-hcv-and-hiv-co-infection-130432https://curecurrent.com/trials/hsv-2-suppression-to-reduce-maternal-hiv-1-rna-levels-during-pregnancy-and-breastfeeding-130433https://curecurrent.com/trials/anti-hiv-false-positivity-rate-in-pregnant-women-and-investigating-the-factors-affecting-this-situation-130434https://curecurrent.com/trials/prospective-study-of-hiv-infection-in-hemophiliacs-130435https://curecurrent.com/trials/what-happens-in-vegas-pep-to-prep-opportunities-130436https://curecurrent.com/trials/long-term-follow-up-study-of-human-immunodeficiency-virus-type-1-hiv-1-positive-patients-who-have-received-oz1-gene-ther-130437https://curecurrent.com/trials/the-health-check-up-for-expectant-moms-130438https://curecurrent.com/trials/effect-of-raltegravir-on-endothelial-function-in-hiv-infected-patients-130439https://curecurrent.com/trials/alcohol-and-art-adherence-in-india-130440https://curecurrent.com/trials/a-randomized-trial-to-prevent-hiv-among-gay-couples-130441https://curecurrent.com/trials/effects-of-contraceptive-ring-on-vaginal-microbiota-hiv-shedding-and-local-immunity-130442https://curecurrent.com/trials/sex-hormone-therapy-and-mucosal-tissues-130443https://curecurrent.com/trials/exploratory-study-of-cellular-reservoirs-in-blood-from-hiv-infected-patients-130444https://curecurrent.com/trials/safety-and-tolerability-study-to-evaluate-lower-dose-of-gsk2248761-in-antiretroviral-treatment-naive-hiv-1-infected-adul-130445https://curecurrent.com/trials/an-observational-study-of-people-who-have-recently-been-infected-with-hiv-130446https://curecurrent.com/trials/gender-affirmative-transgender-care-to-improve-the-hiv-treatment-cascade-130447https://curecurrent.com/trials/home-based-intervention-to-test-and-start-130448https://curecurrent.com/trials/performance-and-usability-evaluation-of-the-atomo-hiv-self-test-130449https://curecurrent.com/trials/study-to-evaluate-the-safety-of-griffithsin-in-a-carrageenan-gel-in-healthy-women-130450https://curecurrent.com/trials/a-phase-i-study-of-an-hiv-vaccine-in-healthy-hiv-uninfected-adults-130451https://curecurrent.com/trials/peer-delivery-of-hiv-self-test-to-improve-linkage-to-hiv-prevention-130452https://curecurrent.com/trials/foster-teens-risk-during-transition-130453https://curecurrent.com/trials/effects-of-supervised-exercise-on-physical-health-and-quality-of-life-among-older-hiv-adults-130454https://curecurrent.com/trials/targeting-effective-analgesia-in-clinics-for-hiv-patient-cohort-130455https://curecurrent.com/trials/hiv-resistant-gene-modified-stem-cells-and-chemotherapy-in-treating-patients-with-lymphoma-with-hiv-infection-130456https://curecurrent.com/trials/steadyrx-smartphone-art-adherence-intervention-for-drug-users-130457https://curecurrent.com/trials/targeting-effective-analgesia-in-clinics-for-hiv-intervention-130458https://curecurrent.com/trials/safety-and-efficacy-of-e-c-f-taf-genvoya-versus-e-c-f-tdf-stribild-in-hiv-1-infected-antiretroviral-treatment-naive-adul-130459https://curecurrent.com/trials/efficacy-and-safety-of-elvitegravir-cobicistat-emtricitabine-tenofovir-alafenamide-in-hiv-1-infected-adolescents-130460https://curecurrent.com/trials/study-to-evaluate-the-safety-and-efficacy-of-e-c-f-taf-genvoya-versus-e-c-f-tdf-stribild-in-hiv-1-positive-antiretrovira-130461https://curecurrent.com/trials/improving-identification-of-mental-health-substance-use-disorders-in-hiv-primary-care-pilot-clinical-response-130462https://curecurrent.com/trials/phase-3-open-label-study-to-evaluate-switching-from-optimized-stable-antiretroviral-regimens-containing-darunavir-to-elv-130463https://curecurrent.com/trials/safety-and-efficacy-of-ledipasvir-sofosbuvir-ldv-sof-fixed-dose-combination-fdc-for-6-weeks-in-adults-with-acute-genotyp-130464https://curecurrent.com/trials/efficacy-and-safety-of-sofosbuvir-velpatasvir-fixed-dose-combination-for-12-weeks-in-adults-with-chronic-hepatitis-c-vir-130465https://curecurrent.com/trials/efficacy-of-tenofovir-alafenamide-versus-placebo-added-to-a-failing-regimen-followed-by-treatment-with-elvitegravir-cobi-130466https://curecurrent.com/trials/efficacy-and-safety-of-e-c-f-taf-genvoya-in-hiv-1-hepatitis-b-co-infected-adults-130467https://curecurrent.com/trials/efficacy-and-safety-of-ledipasvir-sofosbuvir-fixed-dose-combination-for-12-weeks-in-subjects-with-chronic-genotype-1-or-130468https://curecurrent.com/trials/safety-and-efficacy-of-ledipasvir-sofosbuvir-in-adults-with-chronic-hcv-infection-130469https://curecurrent.com/trials/shift-studying-hiv-immunology-after-fecal-transplant-130470https://curecurrent.com/trials/improving-art-retention-and-adherence-in-uganda-the-wisemama-study-130471https://curecurrent.com/trials/validation-of-a-community-survey-methodology-for-measuring-pmtct-program-impact-130472https://curecurrent.com/trials/sexual-hepatitis-c-in-hiv-positive-men-who-have-sex-with-men-msm-in-bordeaux-130473https://curecurrent.com/trials/a-study-to-evaluate-the-pharmacokinetic-effects-of-different-storage-conditions-for-a-long-acting-nanosuspension-of-rilp-130474https://curecurrent.com/trials/safety-and-efficacy-of-switching-from-regimens-of-abc-3tc-a-3rd-agent-to-e-c-f-taf-fixed-dose-combination-fdc-in-virolog-130475https://curecurrent.com/trials/hiv-attachment-inhibitor-to-treat-human-immunodeficiency-virus-1-hiv-1-infections-130476https://curecurrent.com/trials/efficacy-safety-and-tolerability-of-ledipasvir-sofosbuvir-ldv-sof-treatment-for-hiv-hcv-co-infected-participants-who-swi-130477https://curecurrent.com/trials/study-to-evaluate-the-efficacy-of-monotherapy-of-tivicay-versus-a-triple-therapy-in-hiv-1-infected-patients-130478https://curecurrent.com/trials/evaluation-of-nelfinavir-and-chemoradiation-for-pancreatic-cancer-130479https://curecurrent.com/trials/outcomes-of-women-after-obstetric-fistula-repair-130480https://curecurrent.com/trials/phase-iiib-study-evaluating-the-effects-of-atazanavir-powder-with-ritonavir-in-hiv-infected-pediatric-patients-130481https://curecurrent.com/trials/zinc-for-hiv-disease-among-alcohol-users-an-rct-in-the-russia-arch-cohort-130482https://curecurrent.com/trials/early-bactericidal-activity-of-linezolid-gatifloxacin-levofloxacin-isoniazid-inh-and-moxifloxacin-in-hiv-negative-adults-130483https://curecurrent.com/trials/tuberculosis-treatment-shortening-trial-130484https://curecurrent.com/trials/adherence-to-hiv-therapy-in-heroin-addicts-oral-vs-xr-ntx-130485https://curecurrent.com/trials/safety-and-effectiveness-of-raltegravir-plus-darunavir-ritonavir-in-treatment-naive-hiv-infected-adults-130486https://curecurrent.com/trials/the-start-a-streamlined-art-initiation-strategy-study-130487https://curecurrent.com/trials/cc-11050-in-human-immunodeficiency-virus-1-infected-adults-with-suppressed-plasma-viremia-on-antiretroviral-therapy-aphr-130488https://curecurrent.com/trials/tenofovir-alafenamide-fumarate-taf-effect-on-residual-intrathecal-immune-activation-130489https://curecurrent.com/trials/vioone-hiv-profile-supplemental-assay-130490https://curecurrent.com/trials/study-of-chemokine-coreceptor-5-ccr5-antagonist-gw873140-in-r5-tropic-treatment-experienced-hiv-infected-subjects-130491https://curecurrent.com/trials/health-improvement-for-baltimore-youth-130492https://curecurrent.com/trials/comparative-study-of-pk-and-be-of-vm-1500fdc-fixed-dose-combination-and-elpida-with-truvada-o-administrated-1-daily-fast-130493https://curecurrent.com/trials/microbiota-restoration-therapy-in-hiv-with-repeated-low-dose-interventions-130494https://curecurrent.com/trials/retention-and-duration-of-activity-of-spl7013-vivagel-after-vaginal-dosing-130495https://curecurrent.com/trials/tele-ipt-for-hiv-infected-rural-persons-130496https://curecurrent.com/trials/improving-provider-counseling-interventions-in-hiv-practice-130497https://curecurrent.com/trials/a-phase-ii-trial-of-col-3-in-patients-with-hiv-related-kaposi-s-sarcoma-130498https://curecurrent.com/trials/nutritional-support-for-hiv-tuberculosis-co-infected-adults-in-senegal-west-africa-130499https://curecurrent.com/trials/the-peer-support-intervention-supporting-hiv-positive-adolescents-in-zimbabwe-to-improve-hiv-care-continuum-outcomes-130500https://curecurrent.com/trials/operations-research-of-the-real-world-effectiveness-of-multi-month-dispensing-of-art-for-stable-patients-in-cargs-in-zim-130501https://curecurrent.com/trials/bone-mineral-density-changes-in-hiv-positive-females-with-osteopenia-switching-to-raltegravir-130502https://curecurrent.com/trials/reducing-hiv-risk-among-adolescents-evaluating-project-heart-130503https://curecurrent.com/trials/study-to-evaluate-long-term-maintenance-with-trizivir-after-boosted-protease-inhibitor-pi-or-non-nucleoside-reverse-tran-130504https://curecurrent.com/trials/enhancing-ugandan-hiv-affected-child-development-with-caregiver-training-130505https://curecurrent.com/trials/antiplatelet-therapy-in-hiv-130506https://curecurrent.com/trials/secondary-distribution-of-hiv-self-tests-through-antenatal-care-clinic-attendees-and-index-clients-130507https://curecurrent.com/trials/hiv-treatment-reinitiation-in-women-who-received-anti-hiv-drugs-to-prevent-mother-to-child-transmission-of-hiv-130508https://curecurrent.com/trials/early-simplified-a-trial-to-compare-the-efficacy-of-standard-of-care-combination-antiretroviral-therapy-with-a-simplifie-130509https://curecurrent.com/trials/enhancing-the-role-of-commune-health-workers-in-hiv-and-drug-control-a-randomized-controlled-trial-130510https://curecurrent.com/trials/eltrombopag-to-reduce-the-need-for-platelet-transfusion-in-subjects-with-chronic-liver-disease-and-thrombocytopenia-unde-130511https://curecurrent.com/trials/bridges-to-the-future-economic-empowerment-for-aids-orphaned-children-in-uganda-130512https://curecurrent.com/trials/efavirenz-or-atazanavir-ritonavir-given-with-emtricitabine-tenofovir-disoproxil-fumarate-or-abacavir-lamivudine-in-hiv-i-130513https://curecurrent.com/trials/nnrti-vs-pi-regimens-for-hiv-infected-women-after-they-have-taken-nevirapine-to-prevent-mother-to-child-hiv-transmission-130514https://curecurrent.com/trials/adding-maraviroc-to-antiretroviral-therapy-for-suboptimal-cd4-t-cell-recovery-despite-sustained-virologic-suppression-130515https://curecurrent.com/trials/cryptoart-study-decreasing-mortality-associated-with-initiation-of-antiretroviral-therapy-in-sub-saharan-africa-130516https://curecurrent.com/trials/reducing-hazardous-alcohol-use-human-immunodeficiency-virus-hiv-viral-load-130517https://curecurrent.com/trials/determining-the-effects-of-observed-and-self-administered-drug-regimens-in-hiv-infected-adults-130518https://curecurrent.com/trials/high-dose-vitamin-d-and-calcium-for-bone-health-in-individuals-initiating-haart-130519https://curecurrent.com/trials/herpes-simplex-virus-type-2-hsv-2-suppression-to-prevent-hiv-transmission-130520https://curecurrent.com/trials/pioglitazone-before-peginterferon-and-ribavirin-for-hepatitis-c-infection-in-hiv-hcv-coinfected-patients-with-insulin-re-130521https://curecurrent.com/trials/the-hj-mile-hiv-prevention-intervention-for-post-incarcerated-men-130522https://curecurrent.com/trials/immediate-versus-deferred-start-of-anti-hiv-therapy-in-hiv-infected-adults-being-treated-for-tuberculosis-130523https://curecurrent.com/trials/a-study-to-assess-the-safety-of-hiv-and-hep-c-vaccine-candidates-when-given-separately-or-in-combination-130524https://curecurrent.com/trials/nine-month-course-of-anti-hiv-medications-for-people-recently-infected-with-hiv-130525https://curecurrent.com/trials/asymptomatic-leishmania-infection-in-hiv-patients-130526https://curecurrent.com/trials/demonstrating-safety-and-effective-delivery-of-daily-oral-pre-exposure-prophylaxis-prep-for-sex-workers-in-india-130527https://curecurrent.com/trials/retention-of-women-in-the-pmtct-prevention-of-mother-to-child-transmission-of-hiv-130528https://curecurrent.com/trials/intervention-to-enhance-prep-uptake-and-adherence-in-a-community-based-setting-130529https://curecurrent.com/trials/a-study-to-assess-the-safety-of-hep-c-vaccine-candidates-in-hiv-seropositive-individuals-130530https://curecurrent.com/trials/a-phase-i-study-of-safety-and-immunogenicity-of-the-wrair-hiv-1-vaccine-130531https://curecurrent.com/trials/pilot-testing-of-a-behavioral-intervention-for-chronic-pain-in-individuals-with-hiv-130532https://curecurrent.com/trials/targeting-pm-to-improve-hiv-adherence-in-adolescents-at-risk-for-substance-abuse-130533https://curecurrent.com/trials/prospective-evaluation-of-anti-retroviral-combinations-for-treatment-naive-hiv-infected-persons-in-resource-limited-sett-130534https://curecurrent.com/trials/primary-care-based-interventions-to-reduce-alcohol-use-among-hiv-patients-130535https://curecurrent.com/trials/asha-improving-health-and-nutrition-of-indian-women-with-aids-and-their-children-130536https://curecurrent.com/trials/a-trial-comparing-gsk1349572-50mg-once-daily-to-raltegravir-400mg-twice-daily-130537https://curecurrent.com/trials/substance-abuse-treatment-to-hiv-care-sat2hiv-the-implementation-sustainment-facilitation-experiment-130538https://curecurrent.com/trials/addressing-young-men-s-substance-use-and-hiv-risk-130539https://curecurrent.com/trials/testing-and-linkage-to-care-for-injecting-drug-users-in-kenya-130540https://curecurrent.com/trials/the-effects-of-statin-therapy-on-coronary-flow-reserve-and-inflammatory-markers-in-hiv-positive-patients-130541https://curecurrent.com/trials/study-in-healthy-volunteers-to-investigate-the-safety-tolerability-and-pharmacokinetics-of-vm-1500-130542https://curecurrent.com/trials/grazoprevir-mk-5172-and-elbasvir-mk-8742-combination-for-chronic-hepatitis-c-virus-hcv-genotypes-1-4-and-6-mk-5172-065-130543https://curecurrent.com/trials/rapid-minimally-invasive-voluntary-adult-male-circumcision-130544https://curecurrent.com/trials/co-adaptation-between-human-immunodeficiency-virus-hiv-and-cluster-of-differentiation-8-cd8-cellular-immunity-130545https://curecurrent.com/trials/inflammasome-activation-via-circulating-metabolites-130546https://curecurrent.com/trials/practice-of-chemical-sex-by-hiv-patients-in-reunion-island-130547https://curecurrent.com/trials/a-treatment-access-program-to-provide-maraviroc-to-eligible-adult-patients-completing-a4001050-study-until-commercial-av-130548https://curecurrent.com/trials/trauma-intervention-for-affect-regulation-aids-and-substances-130549https://curecurrent.com/trials/a-pilot-gaming-adherence-program-for-youth-living-with-hiv-130550https://curecurrent.com/trials/efficacy-safety-and-optimal-dose-of-vm-1500-in-comparison-to-efavirenz-added-to-standard-of-care-antiretroviral-therapy-130551https://curecurrent.com/trials/dose-finding-study-of-bms-955176-to-treat-hiv-1-infected-treatment-naive-adults-130552https://curecurrent.com/trials/feasibility-of-interventions-on-people-who-inject-drugs-in-vietnam-130553https://curecurrent.com/trials/the-impact-of-mentor-mothers-on-pmtct-service-outcomes-in-nigeria-130554https://curecurrent.com/trials/art-readiness-in-hiv-infected-pregnant-women-130555https://curecurrent.com/trials/comprehensive-hiv-prevention-package-for-msm-in-southern-africa-pilot-study-sibanye-health-project-130556https://curecurrent.com/trials/improving-clinic-attendance-for-medication-collection-among-hiv-positive-individuals-in-nepal-130557https://curecurrent.com/trials/124i-fiau-imaging-in-ebv-and-kshv-associated-cancers-130558https://curecurrent.com/trials/study-of-the-prevalence-and-associated-factors-with-hypogonadism-in-hiv-men-130559https://curecurrent.com/trials/safety-and-immunogenicity-study-of-a-candidate-tuberculosis-vaccine-in-human-immunodeficiency-virus-hiv-positive-adults-130560https://curecurrent.com/trials/safer-conception-intervention-for-hiv-1-serodiscordant-couples-130561https://curecurrent.com/trials/long-term-observational-study-in-hiv-subjects-exposed-to-egrifta-130562https://curecurrent.com/trials/efficacy-of-rilpivirine-based-regimens-as-switch-therapy-from-nevirapine-based-regimens-in-hiv-infected-patients-130563https://curecurrent.com/trials/rifaximin-as-a-modulator-of-microbial-translocation-and-immune-activation-130564https://curecurrent.com/trials/increase-hiv-testing-among-truck-drivers-and-female-sex-workers-in-kenya-through-offering-hiv-self-testing-130565https://curecurrent.com/trials/promoting-hiv-self-testing-with-real-time-online-counseling-for-msm-in-hong-kong-130566https://curecurrent.com/trials/phase-4-field-trial-of-the-unicirc-instrument-with-tissue-adhesive-130567https://curecurrent.com/trials/effect-of-hiv-and-or-active-tuberculosis-on-the-immune-responses-to-trivalent-influenza-vaccine-tiv-in-adults-130568https://curecurrent.com/trials/swiss-hcvree-trial-130569https://curecurrent.com/trials/surveillance-cohort-long-term-toxicity-antiretrovirals-in-hiv-infected-patients-enrolled-in-tpv-cohort-130570https://curecurrent.com/trials/raltegravir-vs-lopinavir-ritonavir-both-in-combination-with-truvada-in-hiv-treatment-naive-individuals-130571https://curecurrent.com/trials/study-of-mk-1972-in-human-immunodeficiency-virus-hiv-1-infected-participants-who-have-not-previously-received-antiretrov-130572https://curecurrent.com/trials/drug-use-and-sexual-risk-behaviors-among-emerging-adults-in-the-er-130573https://curecurrent.com/trials/assessment-of-cmv-specific-elispot-assay-for-predicting-cmv-co-infection-in-patients-with-pneumocystitis-pneumonia-ace-p-130574https://curecurrent.com/trials/distress-tolerance-and-hiv-prevention-with-xr-ntx-initiation-in-opioid-dependence-130575https://curecurrent.com/trials/angiotensin-receptors-and-age-related-mitochondrial-decline-in-hiv-patients-130576https://curecurrent.com/trials/safety-and-pharmacokinetics-pk-of-a-polyurethane-tenofovir-disoproxil-fumarate-tdf-vaginal-ring-130577https://curecurrent.com/trials/the-effect-of-antacids-on-the-pharmacokinetics-pk-of-raltegravir-in-human-immunodeficiency-virus-hiv-infected-participan-130578https://curecurrent.com/trials/phase-ii-safety-and-acceptability-of-an-investigational-injectable-product-tmc278la-for-pre-exposure-prophylaxis-130579https://curecurrent.com/trials/optimizing-pediatric-hiv-1-treatment-in-infants-with-prophylactic-exposure-to-nevirapine-nairobi-kenya-130580https://curecurrent.com/trials/safety-and-immunogenicity-of-a-candidate-tuberculosis-tb-vaccine-in-hiv-positive-adults-130581https://curecurrent.com/trials/a-pharmacokinetic-study-to-evaluate-the-effect-of-maalox-on-raltegravir-mk-0518-in-human-immunodeficiency-virus-hiv-infe-130582https://curecurrent.com/trials/randomized-double-blind-study-comparing-dexelvucitabine-dfc-to-lamivudine-3tc-in-subjects-with-resistance-to-nrtis-pis-a-130583https://curecurrent.com/trials/causes-of-rotavirus-vaccine-failure-in-zambian-children-130584https://curecurrent.com/trials/post-licensure-safety-study-of-isentress-raltegravir-in-a-united-states-managed-care-network-mk-0518-268-130585https://curecurrent.com/trials/follow-up-of-thai-adult-volunteers-with-breakthrough-hiv-infection-after-participation-in-a-preventive-hiv-vaccine-trial-130586https://curecurrent.com/trials/hiv-self-testing-in-implementation-prep-study-130587https://curecurrent.com/trials/management-by-individual-cognitive-remediation-of-cognitive-disorders-of-hiv-infected-patients-130588https://curecurrent.com/trials/3bnc117-and-10-1074-in-hiv-infected-individuals-130589https://curecurrent.com/trials/a-study-of-the-safety-tolerability-and-antiretroviral-activity-of-raltegravir-mk-0518-in-combination-with-other-antiretr-130590https://curecurrent.com/trials/safety-and-pharmacokinetics-pk-of-a-polyurethane-tenofovir-disoproxil-fumarate-tdf-vaginal-ring-tdf-ivr-002-130591https://curecurrent.com/trials/germinal-transmission-after-endogenization-of-hiv-sequences-without-a-competent-virus-for-replication-and-a-potential-pr-130592https://curecurrent.com/trials/liver-steatosis-and-stiffness-in-hiv-130593https://curecurrent.com/trials/engagement-to-care-south-africa-130594https://curecurrent.com/trials/safety-and-immunogenicity-of-a-candidate-tuberculosis-tb-vaccine-in-adults-with-tb-disease-130595https://curecurrent.com/trials/strategy-confirming-study-of-bms-955176-to-treat-hiv-1-infected-treatment-experienced-adults-130596https://curecurrent.com/trials/pharmacokinetics-safety-and-efficacy-of-elvitegravir-cobicistat-emtricitabine-tenofovir-disoproxil-fumarate-single-table-130597https://curecurrent.com/trials/primary-and-booster-vaccination-study-with-a-pneumococcal-vaccine-in-hiv-infected-hiv-exposed-uninfected-and-hiv-uninfec-130598https://curecurrent.com/trials/safety-and-immunogenicity-of-a-candidate-tuberculosis-tb-vaccine-in-healthy-hiv-negative-adolescents-130599https://curecurrent.com/trials/evaluation-of-the-immune-response-of-a-hiv-candidate-vaccine-after-administration-of-one-chloroquine-dose-130600https://curecurrent.com/trials/examining-hiv-treatment-adherence-during-early-disease-130601https://curecurrent.com/trials/community-based-treatment-of-chronic-hepatitis-c-monoinfection-and-coinfection-with-hiv-in-the-district-of-columbia-130602https://curecurrent.com/trials/dardar-nutrition-study-in-hiv-breastfeeding-women-130603https://curecurrent.com/trials/a-prospective-non-interventional-study-of-the-use-of-dolutegravir-as-part-of-combination-antiretroviral-therapy-in-routi-130604https://curecurrent.com/trials/using-cbpr-to-reduce-hiv-risk-among-immigrant-latino-msm-130605https://curecurrent.com/trials/prognosis-of-a-first-ever-stroke-in-persons-living-with-hiv-130606https://curecurrent.com/trials/role-of-the-il33-amphiregulin-pathway-as-a-potential-therapeutic-target-in-hiv-infection-130607https://curecurrent.com/trials/the-study-of-the-prevalence-of-helicobacter-pylori-infection-among-hiv-aids-cohort-130608https://curecurrent.com/trials/an-open-label-randomized-multicenter-phase-iii-clinical-study-comparing-safety-and-efficacy-of-algeron-cepeginterferon-a-130609https://curecurrent.com/trials/two-part-study-to-evaluate-pharmacokinetics-safety-and-antiviral-activity-of-elvitegravir-administered-with-a-pi-r-backg-130610https://curecurrent.com/trials/management-of-highly-active-anti-retroviral-therapy-related-hyperlipidemia-among-hiv-infected-patients-in-taiwan-130611https://curecurrent.com/trials/evaluating-the-effect-of-changing-enfuvirtide-to-raltegravir-in-hiv-infected-subjects-130612https://curecurrent.com/trials/multicomponent-intervention-to-reduce-sexual-risk-and-substance-use-130613https://curecurrent.com/trials/transprep-social-network-based-prep-adherence-for-transgender-women-in-peru-130614https://curecurrent.com/trials/sti-screening-as-a-combined-hiv-prevention-platform-for-msm-in-peru-130615https://curecurrent.com/trials/influenza-vaccine-trial-in-hiv-uninfected-pregnant-women-130616https://curecurrent.com/trials/the-vmvn-study-virological-monitoring-in-viet-nam-130617https://curecurrent.com/trials/females-of-african-american-legacy-empowering-self-femaales-130618https://curecurrent.com/trials/immune-recovery-in-advanced-arv-na-ve-hiv-1-infected-individuals-taking-dolutegravir-or-ritonavir-boosted-darunavir-130619https://curecurrent.com/trials/reducing-hiv-risk-with-high-risk-hiv-negative-black-msm-passport-to-wellness-130620https://curecurrent.com/trials/implementation-of-prep-to-hiv-in-brazilian-transgender-women-130621https://curecurrent.com/trials/implementing-technology-assisted-drug-treatment-and-relapse-prevention-in-federally-qualified-health-centers-fqhcs-130622https://curecurrent.com/trials/community-based-interventions-to-increase-hiv-testing-and-hiv-care-utilization-130623https://curecurrent.com/trials/switch-to-unboosted-atazanavir-with-tenofovir-study-130624https://curecurrent.com/trials/immunogenicity-and-safety-of-the-yellow-fever-vaccine-in-hiv-infected-individuals-130625https://curecurrent.com/trials/regional-bone-turnover-using-18f-fluoride-pet-ct-in-hiv-1-infected-men-petram-study-130626https://curecurrent.com/trials/point-of-care-early-infant-diagnosis-patient-impact-study-130627https://curecurrent.com/trials/high-dose-intravitreal-injection-of-ganciclovir-for-the-treatment-of-cmvr-in-hiv-negative-patients-130628https://curecurrent.com/trials/evaluation-of-enhanced-syphilis-screening-among-hiv-positive-men-130629https://curecurrent.com/trials/optimizing-pediatric-hiv-1-treatment-nairobi-kenya-130630https://curecurrent.com/trials/cash-transfer-to-adolescent-girls-and-young-women-to-reduce-sexual-risk-behavior-an-impact-evaluation-130631https://curecurrent.com/trials/engagement-in-hiv-primary-care-services-130632https://curecurrent.com/trials/fem-prep-truvada-study-to-assess-the-role-of-truvada-in-preventing-hiv-acquisition-in-women-130633https://curecurrent.com/trials/pilot-study-of-liposomal-doxorubicin-combined-with-bevacizumab-followed-by-bevacizumab-monotherapy-in-adults-with-advanc-130634https://curecurrent.com/trials/relationship-between-neuromuscular-fatigue-perceived-tiredness-and-level-of-physical-activity-of-patients-living-with-hi-130635https://curecurrent.com/trials/evaluation-of-therapeutic-management-in-esbl-infected-patients-or-carriers-by-providing-and-sharing-a-free-tool-the-esbl-130636https://curecurrent.com/trials/a-small-group-intervention-to-reduce-hiv-sexual-transmission-risk-behavior-among-hiv-positive-men-who-have-sex-with-men-130637https://curecurrent.com/trials/treatment-of-abnormal-adipose-tissue-accumulation-in-human-immunodeficiency-virus-hiv-patients-130638https://curecurrent.com/trials/observational-study-of-hiv-associated-neurocognitive-disorder-130639https://curecurrent.com/trials/substance-treatment-and-hiv-testing-and-referral-system-130640https://curecurrent.com/trials/finding-the-right-tenofovir-emtricitabine-regimen-for-pre-exposure-prophylaxis-prep-in-transgender-women-130641https://curecurrent.com/trials/cbsm-intervention-via-mhealth-to-ameliorate-hiv-related-fatigue-130642https://curecurrent.com/trials/maxart-early-access-to-art-for-all-in-swaziland-130643https://curecurrent.com/trials/protect-and-connect-couple-hiv-prevention-for-drug-involved-male-offenders-130644https://curecurrent.com/trials/nevirapine-3tc-based-maintenance-therapy-for-hiv-infection-130645https://curecurrent.com/trials/hiv-monotherapy-in-switzerland-most-ch-130646https://curecurrent.com/trials/safety-of-and-immunogenicity-to-an-h1n1-influenza-vaccine-in-hiv-infected-adults-130647https://curecurrent.com/trials/cardiometabolic-effects-of-eplerenone-in-hiv-infection-130648https://curecurrent.com/trials/social-networks-and-prevention-for-hiv-care-and-prevention-130649https://curecurrent.com/trials/seroprevalence-of-hepatitis-e-in-hiv-positive-patients-in-basque-country-in-2016-vihvhepb-130650https://curecurrent.com/trials/reducing-offenders-hiv-risk-mi-enhanced-case-management-with-drug-free-housing-130651https://curecurrent.com/trials/screening-strategy-for-asymptomatic-sexually-transmitted-infections-sti-in-a-cohort-of-hiv-outpatients-men-who-have-sex-130652https://curecurrent.com/trials/peer-outreach-and-navigation-intervention-to-increase-prep-uptake-among-women-at-high-risk-for-hiv-130653https://curecurrent.com/trials/study-on-effects-of-bms-955176-on-the-pharmacokinetics-of-probe-substrates-130654https://curecurrent.com/trials/examining-the-link-between-heart-disease-and-hiv-infection-in-women-130655https://curecurrent.com/trials/investigator-sponsored-protocol-continued-use-of-ibalizumab-130656https://curecurrent.com/trials/growing-up-intervening-with-hiv-positive-adolescents-in-resource-poor-settings-130657https://curecurrent.com/trials/american-ginseng-to-improve-hiv-associated-fatigue-a-randomized-placebo-controlled-parallel-design-multiple-dose-clinica-130658https://curecurrent.com/trials/clinical-trial-to-reduce-drinking-in-women-with-hiv-130659https://curecurrent.com/trials/neuropsychiatric-side-effects-of-efavirenz-in-children-living-with-hiv-130660https://curecurrent.com/trials/a-comprehensive-approach-to-secondary-hiv-prevention-and-care-among-positives-130661https://curecurrent.com/trials/a-single-arm-open-label-study-to-assess-the-pharmacokinetics-of-darunavir-and-ritonavir-darunavir-and-cobicistat-etravir-130662https://curecurrent.com/trials/vedolizumab-treatment-in-hiv-infected-subjects-without-previous-antiretroviral-therapy-130663https://curecurrent.com/trials/lymphocyte-infusions-for-the-treatment-of-hiv-infected-patients-failing-anti-hiv-therapy-130664https://curecurrent.com/trials/antiretroviral-drug-interaction-study-in-volunteers-with-hiv-130665https://curecurrent.com/trials/study-assessing-dolutegravir-in-hiv-1-infected-subjects-with-virus-resistant-to-raltegravir-and-or-elivitegravir-130666https://curecurrent.com/trials/dolutegravir-based-dual-therapies-in-hiv-infected-patients-with-virological-suppression-130667https://curecurrent.com/trials/bitherapy-with-the-combination-of-raltegravir-and-darunavir-birdi-130668https://curecurrent.com/trials/prevalence-of-vertebral-fractures-in-hiv-infected-patients-older-than-50-years-130669https://curecurrent.com/trials/being-safe-in-treatment-130670https://curecurrent.com/trials/prevalence-of-lipodystrophy-syndrome-and-its-role-as-cause-of-metabolic-disturbances-130671https://curecurrent.com/trials/an-observational-retrospective-database-analysis-to-evaluate-raltegravir-based-regimens-in-aged-hiv-patients-ralage-130672https://curecurrent.com/trials/hiv-and-ovarian-reserve-130673https://curecurrent.com/trials/omega-3-supplementation-and-depression-clinical-trial-130674https://curecurrent.com/trials/evaluation-of-low-dose-darunavir-in-a-switch-study-130675https://curecurrent.com/trials/bone-loss-and-immune-reconstitution-in-hiv-aids-blir-hiv-130676https://curecurrent.com/trials/effect-of-supplementation-of-bioactive-compounds-on-the-energy-metabolism-of-people-living-with-hiv-aids-130677https://curecurrent.com/trials/linking-infectious-and-narcology-care-in-russia-130678https://curecurrent.com/trials/ziagen-post-marketing-surveillance-130679https://curecurrent.com/trials/evaluation-of-an-integrated-economic-strengthening-and-hiv-prevention-program-for-vulnerable-youth-in-south-africa-130680https://curecurrent.com/trials/safety-of-the-hiv-vaccine-732462-in-hiv-infected-subjects-aged-18-to-55-years-old-130681https://curecurrent.com/trials/sitagliptin-for-reducing-inflammation-and-immune-activation-130682https://curecurrent.com/trials/eplerenone-in-hiv-associated-abdominal-fat-accumulation-130683https://curecurrent.com/trials/tmao-and-atherosclerosis-in-hiv-130684https://curecurrent.com/trials/impact-of-hiv-drug-resistance-testing-and-subsequent-change-to-an-individualized-therapy-in-tanzania-130685https://curecurrent.com/trials/arv-concentrations-in-hair-130686https://curecurrent.com/trials/group-clinical-visit-adherence-intervention-for-hiv-women-of-color-130687https://curecurrent.com/trials/trial-to-study-the-effect-of-dose-of-herpes-simplex-virus-2-hsv-2-suppressive-therapy-on-hsv-and-hiv-130688https://curecurrent.com/trials/imatinib-mesylate-in-treating-patients-with-hiv-related-kaposi-s-sarcoma-130689https://curecurrent.com/trials/ptc299-in-treating-patients-with-hiv-related-kaposi-sarcoma-130690https://curecurrent.com/trials/raltegravir-in-the-swiss-hiv-cohort-study-130691https://curecurrent.com/trials/diagnostic-of-human-immunodeficiency-virus-hiv-and-other-sexual-transmission-diseases-std-in-high-risk-populations-men-w-130692https://curecurrent.com/trials/rituximab-and-combination-chemotherapy-in-treating-patients-with-newly-diagnosed-hiv-associated-burkitt-s-lymphoma-130693https://curecurrent.com/trials/evaluation-of-the-accucirc-for-early-infant-male-circumcision-in-nyanza-kenya-130694https://curecurrent.com/trials/abnormal-glucose-metabolism-in-hiv-infected-patients-130695https://curecurrent.com/trials/ferumoxytol-enhanced-brain-mri-in-hiv-associated-neurocognitive-disorders-130696https://curecurrent.com/trials/impact-of-screening-patients-with-hiv-for-kidney-disease-130697https://curecurrent.com/trials/prince-study-of-atazanavir-atv-ritonavir-rtv-130698https://curecurrent.com/trials/targeted-clinical-strategies-and-low-level-viraemia-llv-in-boosted-protease-inhibitor-therapy-130699https://curecurrent.com/trials/the-pharmacokinetics-of-dolutegravir-darunavir-cobocistat-when-co-administered-in-healthy-volunteers-130700https://curecurrent.com/trials/antioxidant-in-patients-hiv-supplemented-with-microencapsulated-of-red-pomegranate-130701https://curecurrent.com/trials/hiv-in-orthopaedic-skeletal-trauma-study-130702https://curecurrent.com/trials/pk-and-safety-study-of-vaginal-rings-containing-dapivirine-and-levonorgestrel-130703https://curecurrent.com/trials/sepa-iii-the-effectiveness-trial-130704https://curecurrent.com/trials/efficacy-and-safety-of-gsk-biologicals-hiv-vaccine-in-antiretroviral-therapy-art-na-ve-hiv-1-infected-persons-130705https://curecurrent.com/trials/the-quatro-study-acceptability-study-of-placebo-vaginal-delivery-forms-for-preventing-hiv-and-unintended-pregnancy-130706https://curecurrent.com/trials/prepared-and-strong-clinic-based-prep-for-black-msm-130707https://curecurrent.com/trials/a-study-of-the-pharmacokinetics-and-safety-of-bms-663068-administered-in-subjects-with-normal-renal-function-and-with-mi-130708https://curecurrent.com/trials/hiv-self-testing-africa-star-malawi-general-population-130709https://curecurrent.com/trials/hiv-self-testing-africa-zambia-130710https://curecurrent.com/trials/pediatric-urgent-start-of-highly-active-antiretroviral-treatment-haart-130711https://curecurrent.com/trials/hpv-test-and-treat-strategy-versus-cytology-based-strategy-for-prevention-of-cin2-in-hiv-infected-women-130712https://curecurrent.com/trials/pharmacokinetics-and-pharmacodynamics-of-the-etonogestrel-contraceptive-implant-when-co-administered-with-efavirenz-130713https://curecurrent.com/trials/behavioral-intervention-to-enhance-hiv-test-treat-130714https://curecurrent.com/trials/substance-abuse-treatment-to-hiv-care-sat2hiv-the-motivational-interviewing-based-brief-intervention-experiment-130715https://curecurrent.com/trials/texting-to-improve-testing-textit-130716https://curecurrent.com/trials/zambian-peer-educators-for-hiv-self-testing-study-130717https://curecurrent.com/trials/impact-of-hiv-self-testing-among-female-sex-workers-in-kampala-uganda-130718https://curecurrent.com/trials/will-having-alcohol-treatment-improve-functioning-130719https://curecurrent.com/trials/strategic-screening-for-infectious-diseases-tuberculosis-hiv-hbv-hcv-amongst-migrants-in-france-130720https://curecurrent.com/trials/cpap-improving-mortality-for-pneumonia-in-african-children-trial-130721https://curecurrent.com/trials/phat-life-preventing-hiv-aids-among-teens-in-juvenile-justice-130722https://curecurrent.com/trials/modifiers-of-tenofovir-in-the-female-genital-tract-130723https://curecurrent.com/trials/study-to-evaluate-gsk-biologicals-herpes-zoster-vaccine-gsk1437173a-in-human-immunodeficiency-virus-hiv-infected-subject-130724https://curecurrent.com/trials/american-indian-and-alaska-native-men-who-have-sex-with-men-hiv-substance-abuse-research-130725https://curecurrent.com/trials/a-comparison-of-adherence-rates-to-ritonavir-and-its-accompanying-protease-inhibitor-130726https://curecurrent.com/trials/a-trial-to-determine-the-long-term-durability-of-virologic-suppression-in-kaletra-recipients-with-imperfect-adherence-130727https://curecurrent.com/trials/safety-sudy-of-atazanavir-boosted-with-ritonavir-in-the-treatment-of-hiv-infection-in-pediatric-patients-130728https://curecurrent.com/trials/a-trial-to-test-the-efficacy-of-a-tailored-intensive-smoking-cessation-intervention-in-persons-with-hiv-pwhs-130729https://curecurrent.com/trials/chidamide-in-combination-with-art-for-reactivation-of-the-latent-hiv-1-reservoir-130730https://curecurrent.com/trials/french-hiv-hbv-cohort-130731https://curecurrent.com/trials/early-cart-and-cart-in-combination-with-autologous-hiv-1-specific-cytotoxic-t-lymphocyte-ctl-infusion-in-the-treatment-o-130732https://curecurrent.com/trials/study-in-hiv1-positive-virosuppressed-patients-currently-intreatment-with-ritonavir-boosted-protease-inhibitors-pi-r-sta-130733https://curecurrent.com/trials/community-home-based-care-intervention-and-its-health-outcome-in-hiv-positive-people-130734https://curecurrent.com/trials/rifampicin-vs-rifabutin-in-hiv-aids-patients-combined-with-tuberculosis-130735https://curecurrent.com/trials/pilot-test-of-a-community-based-buprenorphine-treatment-intervention-130736https://curecurrent.com/trials/niacin-on-immune-activation-a-proof-of-concept-study-130737https://curecurrent.com/trials/using-a-theory-based-sms-vm-intervention-to-improve-sexual-and-reproductive-health-of-female-entertainment-workers-in-ca-130738https://curecurrent.com/trials/experimental-design-of-couple-counseling-and-testing-in-antenatal-clinics-in-dar-es-salaam-tanzania-130739https://curecurrent.com/trials/community-based-evaluation-of-a-pilot-pmtct-project-in-kafue-district-130740https://curecurrent.com/trials/bone-antiresorptive-therapy-with-antiretroviral-initiation-batari-pilot-trial-130741https://curecurrent.com/trials/a-key-link-for-transmission-prevention-130742https://curecurrent.com/trials/fosamprenavir-versus-other-protease-inhibitors-130743https://curecurrent.com/trials/study-to-evaluate-the-safety-and-immunogenicity-of-vpm1002-in-comparison-with-bcg-in-hiv-exposed-unexposed-newborn-infan-130744https://curecurrent.com/trials/hepatitis-c-hcv-cure-and-kidney-health-130745https://curecurrent.com/trials/probiotic-visbiome-for-inflammation-and-translocation-in-hiv-ii-130746https://curecurrent.com/trials/study-on-pharmacokinetics-130747https://curecurrent.com/trials/improving-fibrosis-outcomes-with-metformin-130748https://curecurrent.com/trials/ondansetron-alcohol-use-and-alcohol-related-symptoms-in-hiv-persons-130749https://curecurrent.com/trials/study-of-combined-oral-contraceptive-effects-in-female-subjects-130750https://curecurrent.com/trials/micronutrients-and-antioxidants-in-hiv-infection-130751https://curecurrent.com/trials/3bnc117-and-10-1074-in-hiv-uninfected-adults-130752https://curecurrent.com/trials/taste-properties-of-hiv-inhibitor-130753https://curecurrent.com/trials/study-of-the-absorption-metabolism-and-route-of-elimination-of-a-novel-class-of-anti-hiv-1-drugs-bms-955176-in-humans-130754https://curecurrent.com/trials/evaluation-of-a-new-hiv-prevention-intervention-for-black-bisexually-active-men-130755https://curecurrent.com/trials/a-double-blind-placebo-controlled-study-of-intravenous-immunoglobulin-for-hiv-associated-myelopathy-130756https://curecurrent.com/trials/sysmex-xn-20-analyser-to-assess-lymphocyte-subsets-and-other-haematological-parameters-in-chronic-acute-viral-infections-130757https://curecurrent.com/trials/early-antiviral-therapy-for-critically-ill-hiv-infected-patients-130758https://curecurrent.com/trials/demonstration-project-of-prep-among-female-sex-workers-in-dakar-senegal-130759https://curecurrent.com/trials/smartphone-delivered-automated-video-assisted-smoking-treatment-for-people-living-with-hiv-130760https://curecurrent.com/trials/tenofovir-abacavir-platelet-activation-study-130761https://curecurrent.com/trials/contribution-of-praise-messages-to-hiv-treatment-retention-and-adherence-among-female-sex-workers-in-ethiopia-130762https://curecurrent.com/trials/phase-1-ii-safety-and-immunogenicity-study-of-aeras-404-in-bcg-primed-infants-130763https://curecurrent.com/trials/cardiovascular-risk-in-hiv-patients-switching-from-a-boosted-protease-inhibitor-pi-to-dolutegravir-dtg-130764https://curecurrent.com/trials/a-demonstration-project-to-add-pre-or-post-exposure-prophylaxis-to-combination-hiv-prevention-services-130765https://curecurrent.com/trials/randomized-controlled-trial-of-ways-to-improve-ovc-hiv-prevention-and-well-being-130766https://curecurrent.com/trials/reducing-proviral-hiv-dna-with-interferon-a-130767https://curecurrent.com/trials/evaluating-the-feasibility-and-acceptability-of-implementing-a-prep-program-in-pr-concra-san-juan-puerto-rico-part-a-130768https://curecurrent.com/trials/multiplex-microarray-chip-based-diagnosis-of-respiratory-infections-130769https://curecurrent.com/trials/immune-response-to-mycobacterium-tuberculosis-infection-130770https://curecurrent.com/trials/impact-of-tmp-smx-prophylaxis-on-malaria-infection-and-immunity-in-children-in-uganda-130771https://curecurrent.com/trials/medical-marijuana-use-in-hiv-patients-prospective-cohort-study-130772https://curecurrent.com/trials/evaluating-the-feasibility-and-acceptability-of-implementing-a-prep-program-in-pr-concra-san-juan-puerto-rico-part-b-130773https://curecurrent.com/trials/evaluation-of-albuminuria-hiv-infected-patients-130774https://curecurrent.com/trials/gene-expression-in-hiv-and-tuberculosis-co-infection-130775https://curecurrent.com/trials/collection-of-tissue-specimens-in-mali-west-africa-for-hiv-and-tuberculosis-research-130776https://curecurrent.com/trials/response-to-standard-hiv-treatment-in-bamako-mali-130777https://curecurrent.com/trials/a-trial-comparing-gsk1349572-50mg-plus-abacavir-lamivudine-once-daily-to-atripla-also-called-the-single-trial-130778https://curecurrent.com/trials/test-and-treat-tb-a-proof-of-concept-trial-in-south-africa-130779https://curecurrent.com/trials/understanding-medication-adherence-among-hiv-patients-130780https://curecurrent.com/trials/prevalence-knowledge-and-attitude-of-hiv-aids-in-luxor-130781https://curecurrent.com/trials/a-prospective-observational-study-of-pregnancy-outcomes-among-women-exposed-to-truvada-for-prep-indication-130782https://curecurrent.com/trials/hiv-prevention-and-trauma-treatment-for-men-who-have-sex-with-men-with-childhood-sexual-abuse-histories-130783https://curecurrent.com/trials/chinese-network-of-pediatric-antiretroviral-therapy-130784https://curecurrent.com/trials/vietnam-cryptococcal-retention-in-care-study-crics-federal-financial-report-130785https://curecurrent.com/trials/a-study-of-saquinavir-ritonavir-in-liver-impaired-patients-with-hiv-infection-130786https://curecurrent.com/trials/functionality-of-male-condoms-with-a-silicone-elastomer-vaginal-ring-130787https://curecurrent.com/trials/gut-microbiota-and-immune-recovery-130788https://curecurrent.com/trials/a-prospective-observational-drug-utilization-study-of-subjects-taking-truvada-for-pre-exposure-prophylaxis-in-the-usa-130789https://curecurrent.com/trials/safety-effectiveness-of-oral-chemokine-coreceptor-5-ccr5-antagonist-incb009471-in-r5-tropic-hiv-infected-patients-130790https://curecurrent.com/trials/nutraceutical-treatment-for-hypercholesterolemia-in-hiv-infected-patients-130791https://curecurrent.com/trials/a-safety-and-immunogenicity-study-of-3-doses-of-opal-immunotherapy-in-hiv-infected-people-130792https://curecurrent.com/trials/durability-of-adherence-in-self-management-of-hiv-130793https://curecurrent.com/trials/safety-and-effectiveness-of-lopinavir-ritonavir-in-individuals-who-have-failed-prior-hiv-therapy-130794https://curecurrent.com/trials/observational-cohort-of-hiv-infected-adults-and-children-in-the-phpt-network-hospitals-in-thailand-130795https://curecurrent.com/trials/clinical-trial-on-the-effects-of-progestin-based-contraception-in-the-genital-tract-of-hiv-infected-and-uninfected-women-130796https://curecurrent.com/trials/depression-and-art-adherence-in-hiv-latinos-130797https://curecurrent.com/trials/therapeutic-hpv-16-vaccination-for-the-treatment-of-anal-dysplasia-130798https://curecurrent.com/trials/modafinil-treatment-for-cocaine-dependence-and-hiv-high-risk-behavior-130799https://curecurrent.com/trials/safety-and-efficacy-of-switching-from-stavudine-or-zidovudine-to-tenofovir-df-in-hiv-1-infected-children-130800https://curecurrent.com/trials/functional-cure-study-of-hiv-infected-patients-130801https://curecurrent.com/trials/pharmacokinetic-study-of-the-dapivirine-vaginal-ring-in-lactating-women-130802https://curecurrent.com/trials/an-expanded-access-protocol-for-a-single-subject-who-has-completed-24-weeks-of-treatment-in-pr0140-cd02-study-130803https://curecurrent.com/trials/mirtazapine-for-the-treatment-of-methamphetamine-dependence-among-msm-m2-0-130804https://curecurrent.com/trials/enhancement-by-poly-iclc-during-hiv-1-infection-130805https://curecurrent.com/trials/evaluating-demand-creation-strategies-for-voluntary-medical-male-circumcision-vmmc-in-kenya-130806https://curecurrent.com/trials/clinical-trial-to-evaluate-drug-drug-interactions-between-darunavir-cobicistat-and-etravirine-in-hiv-infected-patients-130807https://curecurrent.com/trials/testosterone-and-physical-function-in-hiv-men-130808https://curecurrent.com/trials/vitamin-d-supplementation-in-hiv-youth-130809https://curecurrent.com/trials/a-pilot-study-of-prep-acceptance-among-young-black-msm-130810https://curecurrent.com/trials/hiv-point-of-care-test-evaluation-in-infants-130811https://curecurrent.com/trials/a-trial-to-confirm-a-sustained-virological-suppression-defined-as-hiv-rna-50-copies-ml-of-3-different-doses-of-fozivudin-130812https://curecurrent.com/trials/can-valacyclovir-delay-the-need-for-initiation-of-human-immunodeficiency-virus-hiv-treatment-in-hiv-infected-individuals-130813https://curecurrent.com/trials/the-impact-of-home-delivery-of-antiretroviral-therapy-on-virological-suppression-130814https://curecurrent.com/trials/long-term-follow-up-of-participants-from-studies-evaluating-gsk-hiv-vaccine-130815https://curecurrent.com/trials/probiotic-visbiome-for-inflammation-and-translocation-in-hiv-130816https://curecurrent.com/trials/targeting-platelets-in-chronic-hiv-infection-130817https://curecurrent.com/trials/carolina-alcohol-and-drug-resources-130818https://curecurrent.com/trials/ssat064-pharmacokinetics-of-abacavir-lamivudine-dolutegravir-in-hiv-patients-of-60-years-and-over-130819https://curecurrent.com/trials/postural-stability-deficiencies-in-asymptomatic-individuals-with-hiv-130820https://curecurrent.com/trials/viral-biofilms-hijacking-t-cell-extracellular-matrix-to-regulate-hiv-1-spread-130821https://curecurrent.com/trials/quality-of-life-sleep-and-biomarkers-in-people-with-hiv-aids-130822https://curecurrent.com/trials/a-bundled-rapid-hiv-hcv-testing-intervention-to-increase-receipt-of-test-results-130823https://curecurrent.com/trials/advancing-hiv-prevention-and-linkage-to-care-among-msm-with-gamification-130824https://curecurrent.com/trials/healthy-options-group-psychotherapy-for-hiv-positive-depressed-perinatal-women-130825https://curecurrent.com/trials/medications-for-chronic-hiv-education-and-collaboration-130826https://curecurrent.com/trials/bortezomib-in-treating-patients-with-relapsed-or-refractory-aids-related-kaposi-sarcoma-130827https://curecurrent.com/trials/pk-and-pd-study-of-oral-f-taf-for-hiv-prevention-130828https://curecurrent.com/trials/evaluation-of-implementation-of-pre-exposure-prophylaxis-prep-in-norway-130829https://curecurrent.com/trials/supporting-adolescents-to-adhere-an-intervention-using-airtime-rewards-allocated-by-a-prize-drawing-130830https://curecurrent.com/trials/hiv-awal-early-testing-treatment-indonesia-project-observational-phase-130831https://curecurrent.com/trials/prep-lube-and-the-rectal-mucosa-in-msm-at-risk-of-hiv-130832https://curecurrent.com/trials/outcomes-of-differentiated-models-of-antiretroviral-treatment-art-provision-130833https://curecurrent.com/trials/prevention-of-hiv-infection-in-high-risk-social-networks-of-african-american-men-who-have-sex-with-men-msm-130834https://curecurrent.com/trials/rapid-oral-test-for-therapeutic-response-in-hiv-aids-patients-130835https://curecurrent.com/trials/text-messaging-intervention-to-improve-hiv-adherence-in-rural-drug-users-130836https://curecurrent.com/trials/cardiovascular-radiologic-and-metabolic-assessment-in-hiv-an-investigation-of-pathophysiology-130837https://curecurrent.com/trials/modification-of-doses-of-efavirenz-according-to-its-blood-concentration-in-hiv-patients-130838https://curecurrent.com/trials/rifampin-based-tuberculosis-treatment-versus-rifabutin-based-tuberculosis-treatment-in-persons-with-hiv-130839https://curecurrent.com/trials/postpartum-adherence-clubs-to-enhance-support-the-pacer-study-130840https://curecurrent.com/trials/an-assessment-of-an-hiv-prevention-intervention-project-aim-among-junior-secondary-school-students-in-eastern-botswana-130841https://curecurrent.com/trials/etiology-of-treatment-failure-in-hiv-positive-children-and-adolescents-on-boosted-protease-inhibitor-based-regimens-130842https://curecurrent.com/trials/rift-effect-of-rifampicin-on-plasma-pk-of-ftc-taf-and-intracellular-tfv-dp-ftc-tp-130843https://curecurrent.com/trials/swaziland-safe-generations-130844https://curecurrent.com/trials/combination-of-an-investigational-cannabinoid-and-methadone-for-hiv-associated-neuropathy-130845https://curecurrent.com/trials/clinical-evaluation-of-the-xpert-hiv-1-vl-130846https://curecurrent.com/trials/evaluation-of-xpert-mtb-rif-assay-for-the-rapid-identification-of-tb-and-tb-rifampin-resistance-in-pulmonary-tuberculosi-130847https://curecurrent.com/trials/interventions-for-hiv-mothers-with-problem-drinking-130848https://curecurrent.com/trials/a-study-of-the-safety-pharmacokinetics-and-antiretroviral-activity-of-10-1074-130849https://curecurrent.com/trials/zambia-one-love-aim-3-trial-130850https://curecurrent.com/trials/reducing-hiv-risks-in-african-american-teens-130851https://curecurrent.com/trials/older-hiv-infected-adults-and-drug-interactions-french-cross-sectional-study-130852https://curecurrent.com/trials/real-life-effectiveness-of-the-kaletra-adherence-support-assistance-kasa-program-130853https://curecurrent.com/trials/randomized-trial-of-an-hiv-navigation-program-for-early-palliative-care-130854https://curecurrent.com/trials/effect-of-antibiotics-on-penile-microbiome-and-hiv-susceptibility-study-in-ugandan-men-130855https://curecurrent.com/trials/the-effects-of-the-direct-acting-antiviral-agent-boceprevir-on-the-pharmacokinetics-of-maraviroc-in-healthy-volunteers-130856https://curecurrent.com/trials/sti-care-model-to-reduce-genital-inflammation-and-hiv-risk-in-south-african-women-130857https://curecurrent.com/trials/development-and-testing-of-a-jamaican-mother-daughter-hiv-risk-reduction-program-130858https://curecurrent.com/trials/anrs-co24-oncovihac-onco-vih-anti-checkpoint-130859https://curecurrent.com/trials/careconekta-a-pilot-study-of-a-smartphone-app-in-south-africa-130860https://curecurrent.com/trials/a-phase-1-antiretroviral-drug-drug-interaction-study-in-healthy-volunteers-ddi-130861https://curecurrent.com/trials/safe-generations-plus-swaziland-pmtct-ltf-study-130862https://curecurrent.com/trials/efficacy-of-maraviroc-in-modulating-atherosclerosis-in-hiv-patients-130863https://curecurrent.com/trials/bioequivalency-study-of-zidovudine-under-fasting-conditions-130864https://curecurrent.com/trials/immunogenicity-of-fluzone-high-dose-in-immunocompromised-children-and-young-adults-130865https://curecurrent.com/trials/a-dose-escalation-study-of-mdx-010-administered-monthly-as-immunotherapy-in-subjects-infected-with-human-immunodeficienc-130866https://curecurrent.com/trials/bioequivalency-study-of-zidovudine-under-fed-conditions-130867https://curecurrent.com/trials/preventing-tb-iris-in-high-risk-patients-a-randomized-placebo-controlled-trial-of-prednisone-130868https://curecurrent.com/trials/innovations-in-hiv-testing-ti-130869https://curecurrent.com/trials/characterization-and-modulation-of-mucosal-immunity-for-hiv-prevention-in-women-130870https://curecurrent.com/trials/improving-blood-safety-and-hiv-testing-in-brazil-130871https://curecurrent.com/trials/epic-allies-hiv-art-adherence-intervention-130872https://curecurrent.com/trials/biomarkers-for-muscle-function-and-aging-in-chronic-hiv-infection-130873https://curecurrent.com/trials/an-open-label-demonstration-project-and-phase-ii-safety-study-of-pre-exposure-prophylaxis-use-among-15-to-17-year-old-yo-130874https://curecurrent.com/trials/an-open-label-demonstration-project-and-phase-ii-safety-study-of-pre-exposure-prophylaxis-130875https://curecurrent.com/trials/selective-exposure-in-hiv-prevention-130876https://curecurrent.com/trials/antiretroviral-localization-in-gut-associated-lymphoid-tissue-and-lower-female-genital-tract-tissue-of-hiv-subjects-130877https://curecurrent.com/trials/dolutegravir-compared-to-darunavir-ritonavir-each-in-combination-with-dual-nucleoside-reverse-transcriptase-inhibitors-n-130878https://curecurrent.com/trials/a-dose-ranging-trial-of-gsk1349572-and-2-nrti-in-hiv-1-infected-therapy-naive-subjects-130879https://curecurrent.com/trials/community-based-distribution-of-oral-hiv-self-testing-kits-130880https://curecurrent.com/trials/a-phase-1-randomized-blinded-dose-escalation-study-of-raav1-pg9dp-recombinant-aav-vector-coding-for-pg9-antibody-in-heal-130881https://curecurrent.com/trials/naltrexone-and-behavioral-drug-and-hiv-risk-reduction-counseling-in-russia-130882https://curecurrent.com/trials/sharing-hiv-aids-responsibilities-and-efforts-130883https://curecurrent.com/trials/prevalence-characteristics-and-risk-factors-of-hiv-associated-neurocognitive-disorders-in-subjects-between-the-ages-of-5-130884https://curecurrent.com/trials/infectious-diseases-and-movement-program-study-of-the-effects-of-physical-activity-on-hiv-infection-130885https://curecurrent.com/trials/a-pilot-voucher-incentive-for-improving-retention-in-postpartum-hiv-care-in-south-africa-130886https://curecurrent.com/trials/cell-phone-messaging-to-improve-communication-of-critical-laboratory-results-to-patients-in-rural-uganda-130887https://curecurrent.com/trials/effect-of-vitamin-b-on-plasma-neurofilament-light-protein-nfl-in-hiv-infected-individuals-with-increased-plasma-homocyst-130888https://curecurrent.com/trials/skills-based-counseling-for-adherence-and-depression-in-hiv-methadone-patients-1-130889https://curecurrent.com/trials/pharmacokinetic-effect-of-evotaz-microgynon-co-administration-130890https://curecurrent.com/trials/scale-up-of-an-internet-delivered-study-for-hiv-men-130891https://curecurrent.com/trials/the-therapeutic-workplace-initiation-study-130892https://curecurrent.com/trials/additive-benefit-of-the-urine-lam-test-to-current-tb-diagnostics-in-hiv-positive-adults-in-panama-city-panama-130893https://curecurrent.com/trials/men-together-making-a-difference-reducing-hiv-std-risk-behavior-among-south-african-men-130894https://curecurrent.com/trials/a-commitment-device-for-medication-adherence-among-hiv-patients-130895https://curecurrent.com/trials/interventions-for-hiv-negative-men-and-women-who-have-high-risk-suspected-exposure-to-hiv-130896https://curecurrent.com/trials/validation-study-of-mhealth-technology-in-hiv-to-improve-empowerment-and-healthcare-utilisation-research-and-innovation-130897https://curecurrent.com/trials/study-to-evaluate-the-safety-tolerability-and-acceptability-of-long-acting-injections-of-the-human-immunodeficiency-viru-130898https://curecurrent.com/trials/prison-connect-sti-hiv-prevention-intervention-for-couples-affected-by-incarceration-130899https://curecurrent.com/trials/feasibility-tolerance-and-efficacy-of-interferon-free-antiviral-treatment-with-sofosbuvir-ribavirin-for-the-treatment-of-130900https://curecurrent.com/trials/efficacy-of-an-abstinence-only-hiv-risk-reduction-intervention-for-young-african-american-adolescents-130901https://curecurrent.com/trials/bupropion-for-reducing-high-risk-behaviors-in-depressed-men-who-have-sex-with-men-msm-130902https://curecurrent.com/trials/screening-brief-intervention-referral-to-treatment-sbirt-in-new-mexico-130903https://curecurrent.com/trials/the-self-collection-study-a-study-of-self-collected-hpv-testing-and-results-counseling-130904https://curecurrent.com/trials/statin-therapy-to-improve-atherosclerosis-in-hiv-patients-130905https://curecurrent.com/trials/a-comparative-study-of-mefloquine-and-s-p-as-prophylaxis-against-malaria-in-pregnant-hiv-patients-130906https://curecurrent.com/trials/a-comparative-study-of-azithromycin-and-s-p-as-prophylaxis-in-pregnant-hiv-patients-130907https://curecurrent.com/trials/pilot-study-of-hiv-and-hepatitis-b-and-c-screening-in-surgery-130908https://curecurrent.com/trials/partners-demonstration-project-of-prep-and-art-130909https://curecurrent.com/trials/generic-vel-sof-with-or-without-rbv-for-hiv-hcv-coinfected-patients-130910https://curecurrent.com/trials/early-phase-evaluation-of-abc294640-in-patients-with-refractory-relapsed-diffuse-large-b-cell-lymphoma-or-kaposi-sarcoma-130911https://curecurrent.com/trials/e6-e7-mrna-performance-to-detect-hsil-and-cost-effectiveness-analysis-of-this-screening-strategy-in-hiv-msm-130912https://curecurrent.com/trials/a-self-assessment-intervention-for-young-adult-polydrug-users-at-risk-for-hiv-130913https://curecurrent.com/trials/knowledge-attitudes-behaviours-and-practices-regarding-hiv-of-sex-workers-in-the-french-antilles-130914https://curecurrent.com/trials/study-to-compare-the-safety-and-anti-hiv-effect-of-gsk1265744-versus-placebo-in-hiv-1-infected-adults-itz112929-130915https://curecurrent.com/trials/brief-therapy-intervention-for-heavy-hazardous-drinking-in-hiv-positive-women-130916https://curecurrent.com/trials/a-study-of-maraviroc-in-hiv-co-infected-subjects-with-hepatitis-c-and-or-hepatitis-b-130917https://curecurrent.com/trials/interaction-with-hiv-antiretroviral-agents-130918https://curecurrent.com/trials/predictors-of-time-to-viremia-with-an-analytic-treatment-interruption-130919https://curecurrent.com/trials/knowledge-attitudes-behaviours-and-practices-regarding-hiv-of-men-who-have-sex-with-men-in-the-french-antilles-and-frenc-130920https://curecurrent.com/trials/hiv-sti-prevention-among-black-adolescents-with-mental-illnesses-project-gold-130921https://curecurrent.com/trials/development-of-resistance-mutations-in-pregnant-hiv-positive-women-following-perinatal-antiretroviral-therapy-in-israel-130922https://curecurrent.com/trials/evaluating-the-effectiveness-of-pentoxifylline-at-improving-blood-vessel-function-in-hiv-infected-people-not-receiving-a-130923https://curecurrent.com/trials/a-clinical-trial-comparing-the-efficacy-of-darunavir-ritonavir-monotherapy-versus-a-triple-combination-therapy-containin-130924https://curecurrent.com/trials/reality-check-an-hiv-risk-reduction-serial-drama-130925https://curecurrent.com/trials/enhancing-housing-first-programs-with-a-social-network-substance-use-intervention-130926https://curecurrent.com/trials/cardiovascular-prevention-for-persons-with-hiv-130927https://curecurrent.com/trials/aspirin-and-antiretroviral-therapy-in-hiv-infected-patients-130928https://curecurrent.com/trials/impact-of-cmv-status-on-hiv-viral-load-decay-130929https://curecurrent.com/trials/dolutegravir-impact-on-residual-replication-130930https://curecurrent.com/trials/shedding-immunogenicity-and-safety-of-quadrivalent-live-intranasal-influenza-vaccine-qlaiv-in-hiv-infected-children-and-130931https://curecurrent.com/trials/dose-finding-study-of-gsk2248761-in-antiretroviral-therapy-experienced-subjects-with-nnrti-resistant-hiv-infection-130932https://curecurrent.com/trials/dose-finding-study-of-gsk2248761-in-antiretroviral-therapy-naive-subjects-signet-130933https://curecurrent.com/trials/emtricitabine-tenofovir-alafenamide-as-salvage-art-130934https://curecurrent.com/trials/a-safety-and-immunogenicity-study-of-a-plasmid-dna-prime-and-mva-boost-vaccine-in-hiv-1-infected-adults-on-art-130935https://curecurrent.com/trials/benefit-of-daa-therapy-in-hcv-monoinfected-and-hiv-hcv-coinfected-patients-with-mixed-cryoglobulinemia-130936https://curecurrent.com/trials/modulated-electro-hyperthermia-plus-chemo-radiation-for-locally-advanced-cervical-cancer-patients-in-south-africa-130937https://curecurrent.com/trials/online-social-networking-for-hiv-prevention-130938https://curecurrent.com/trials/feasibility-of-telerehabilitation-in-hiv-patients-130939https://curecurrent.com/trials/zambia-sivet-mmr-tdap-ipv-130940https://curecurrent.com/trials/cohort-of-hiv-associated-lymphomas-130941https://curecurrent.com/trials/reducing-hiv-risk-in-urban-women-soap-opera-videos-on-video-capable-cell-phones-130942https://curecurrent.com/trials/elvitegravir-cobicistat-tenofovir-df-emtricitabine-with-darunavir-treatment-simplification-strategy-130943https://curecurrent.com/trials/hiv-risk-reduction-in-youth-in-the-bahamas-130944https://curecurrent.com/trials/breast-milk-composition-and-hiv-exposed-unexposed-early-infant-growth-and-infectious-disease-events-130945https://curecurrent.com/trials/a-pilot-study-of-monotherapy-of-dolutegravir-in-hiv-1-virologically-suppressed-patients-130946https://curecurrent.com/trials/strength-training-with-vascular-occlusion-in-patients-harboring-with-hiv-aids-130947https://curecurrent.com/trials/to-investigate-the-safety-and-efficacy-of-ub-421-monotherapy-in-hiv-infected-adults-130948https://curecurrent.com/trials/international-hiv-antiretroviral-adherence-resistance-and-survival-130949https://curecurrent.com/trials/vrc-hivmab060-00-ab-vrc01-in-people-with-chronic-hiv-infection-undergoing-analytical-treatment-interruption-130950https://curecurrent.com/trials/social-norms-and-priming-to-improve-adherence-to-antiretroviral-therapy-and-retention-in-care-130951https://curecurrent.com/trials/effects-of-growth-hormone-releasing-hormone-in-hiv-130952https://curecurrent.com/trials/effect-of-switching-atripla-to-eviplera-on-neurocognitive-and-emotional-functioning-130953https://curecurrent.com/trials/optimal-dosing-of-1st-line-antituberculosis-and-antiretroviral-drugs-in-children-a-pharmacokinetic-study-130954https://curecurrent.com/trials/german-centre-for-infection-research-hiv-translational-platform-130955https://curecurrent.com/trials/repeat-sexually-transmitted-infection-sti-patients-tailored-socio-contextual-intervention-to-reduce-hiv-risk-130956https://curecurrent.com/trials/pilot-study-of-diflunisal-in-hiv-infected-adults-130957https://curecurrent.com/trials/ferumoxytol-enhanced-imaging-and-mapping-in-neuroaids-130958https://curecurrent.com/trials/enhancing-prep-in-community-settings-epic-130959https://curecurrent.com/trials/men-s-club-impact-of-male-partner-involvement-on-initiation-and-sustainment-of-exclusive-breastfeeding-among-postpartum-130960https://curecurrent.com/trials/community-based-accompaniment-with-supervised-antiretrovirals-in-lima-peru-130961https://curecurrent.com/trials/effect-of-the-hiv-protease-inhibitors-atazanavir-and-lopinavir-ritonavir-on-cardiovascular-disease-risk-factors-130962https://curecurrent.com/trials/using-hiv-risk-assessment-tool-to-promote-hiv-testing-among-men-who-have-sex-with-men-130963https://curecurrent.com/trials/comprehensive-triaged-hiv-prevention-in-tanzania-130964https://curecurrent.com/trials/effect-of-aspirin-on-abacavir-induced-platelet-reactivity-in-hiv-infected-patients-130965https://curecurrent.com/trials/ssat063-pharmacokinetics-of-efavirenz-400-mg-once-daily-during-pregnancy-in-hiv-1-infected-women-130966https://curecurrent.com/trials/adolescent-coordinated-transition-nigerian-hiv-youth-130967https://curecurrent.com/trials/relative-bioavailability-and-food-effect-for-darunavir-cobicistat-emtricitabine-tenofovir-alafenamide-fixed-dose-combina-130968https://curecurrent.com/trials/hiv-viremia-and-persistence-in-acutely-hiv-infected-patients-treated-with-darunavir-ritonavir-and-etravirine-130969https://curecurrent.com/trials/point-of-delivery-prenatal-test-results-through-mhealth-to-improve-birth-outcome-130970https://curecurrent.com/trials/safety-of-and-immune-response-to-a-modified-vaccinia-ankara-mva-hiv-vaccine-in-hiv-uninfected-adults-130971https://curecurrent.com/trials/phase-ii-motivational-interviewing-an-experiential-online-training-tool-130972https://curecurrent.com/trials/self-managing-hiv-and-chronic-disease-130973https://curecurrent.com/trials/postprandial-endothelial-dysfunction-after-a-high-fat-meal-in-hiv-infected-men-130974https://curecurrent.com/trials/imiquimod-and-influenza-vaccine-for-immunocompromised-patients-130975https://curecurrent.com/trials/male-circumcision-against-hiv-hukomboa-130976https://curecurrent.com/trials/pre-exposure-prophylaxis-and-timed-intercourse-for-hiv-discordant-couples-130977https://curecurrent.com/trials/leukapheresis-for-research-on-hcv-coinfected-patients-130978https://curecurrent.com/trials/relationship-between-fatigue-and-mitochondrial-damage-in-patients-with-hiv-aids-130979https://curecurrent.com/trials/evaluate-weight-gain-using-2-different-formulations-of-megestrol-acetate-oral-suspension-for-aids-related-weight-loss-130980https://curecurrent.com/trials/contextualizing-responding-to-hiv-risk-behaviors-130981https://curecurrent.com/trials/hiv-tb-confections-among-hiv-patients-130982https://curecurrent.com/trials/safety-and-effectiveness-of-different-shangring-device-sizes-for-adult-male-circumcision-in-lusaka-zambia-130983https://curecurrent.com/trials/a-trial-to-assess-the-functionality-of-female-condom-with-a-silicone-elastomer-vaginal-ring-130984https://curecurrent.com/trials/the-effect-of-probiotics-in-hiv-1-infection-130985https://curecurrent.com/trials/school-support-as-structural-hiv-prevention-for-adolescent-orphans-in-kenya-130986https://curecurrent.com/trials/prospective-comparison-between-te-swe-and-mre-fullfibro01-130987https://curecurrent.com/trials/single-dose-pharmacokinetics-of-bms-626529-administered-as-bms-663068-in-subjects-with-hepatic-impairment-compared-to-he-130988https://curecurrent.com/trials/a-open-label-drug-drug-interaction-with-maraviroc-ddi-130989https://curecurrent.com/trials/drug-drug-interaction-ddi-rifabutin-130990https://curecurrent.com/trials/gsk1349572-drug-interaction-study-with-efavirenz-130991https://curecurrent.com/trials/foto-five-consecutive-days-on-treatment-with-efavirenz-tenofovir-and-emtricitabine-followed-by-two-days-off-treatment-ve-130992https://curecurrent.com/trials/safety-effectiveness-and-acceptability-of-sino-implant-ii-in-dr-130993https://curecurrent.com/trials/cognitive-training-for-the-remediation-of-functional-brain-health-in-hiv-130994https://curecurrent.com/trials/evaluation-of-a-peer-education-program-to-promote-family-planning-among-female-sex-workers-in-kenya-130995https://curecurrent.com/trials/hiv-prep-priming-of-immune-effectors-130996https://curecurrent.com/trials/prevention-of-female-genital-schistosomiasis-fgs-in-rural-high-endemic-south-africa-130997https://curecurrent.com/trials/theory-based-text-messaging-to-reduce-methamphetamine-use-and-hiv-risks-among-msm-130998https://curecurrent.com/trials/employment-based-reinforcement-to-motivate-drug-abstinence-in-the-treatment-of-drug-addiction-1-130999https://curecurrent.com/trials/ssat058-atripla-to-eviplera-switch-in-patients-without-central-nervous-system-symptoms-131000https://curecurrent.com/trials/behavioral-consultation-for-hiv-older-adults-prescribed-opioids-for-chronic-pain-131001https://curecurrent.com/trials/enhanced-tb-screening-to-determine-the-prevalence-and-incidence-of-tb-in-patients-with-hiv-131002https://curecurrent.com/trials/acyclovir-therapy-for-genital-herpes-ulcers-in-hiv-negative-african-women-131003https://curecurrent.com/trials/evaluation-of-ptb-screening-in-anc-in-lusaka-zambia-131004https://curecurrent.com/trials/employment-based-reinforcement-of-naltrexone-ingestion-and-abstinence-131005https://curecurrent.com/trials/a-pharmacokinetic-evaluation-of-etonogestrel-eng-implant-and-antiretroviral-therapy-131006https://curecurrent.com/trials/vietnam-cryptococcal-retention-in-care-study-version-1-0-131007https://curecurrent.com/trials/prospective-epidemiological-study-of-the-prevalence-of-hla-b-5701-131008